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ABSTRACT 
 
John Robert Ridpath: Development and Validation of an Assay for the Characterization 
of the DNA Damage Response to Damage Caused by Superfund Chemicals 
(Under the direction of Jun Nakamura) 
 
 
 Determination of intracellular mode of action regarding how chemicals induce 
toxicity plays an important role for establishing risk assessment.  Although several 
methods exist to ascertain how toxic substances act intracellularly, the amount of 
information obtained from these assays usually fails to fully clarify the route to toxicity.  
This projects goal was to establish and validate a new assay to provide more information 
with regard to the DNA damage response of cells to toxic agents.  This assay uses a 
reverse-genetic approach similar to that used with yeast mutants.  We used a cell line 
known as DT40 from a vertebrate source whose mutants have been derived from a single 
parent making the entire cell line isogenic.  The DT40 cell line includes more than 50 
mutants for proteins involved in DNA repair, DNA damage bypass and cell cycle 
checkpoints.  This line is used to study several cellular metabolic processes, but we 
believe we are the first to exploit this exceptional tool to aid in the determination of 
toxicological end-points.  
 First we developed the assay into a relatively rapid and cost-efficient method that 
may be used to screen chemicals, but with accuracy, reliability and sensitivity.  For this, 
we measured the sensitivity of DT40 mutants to chemicals using XTT, a dye reduced 
only in respirating cells, providing a direct measurement of cell proliferation after 
 iii 
treatment.  We found this method both reliable and sensitive as evidenced by validations 
with cisplatin, methyl methanesulfonate and acrolein.  
 We next applied our method to study the DNA damage response to formaldehyde, 
an agent shown to induce DNA-protein crosslinks.  Little was known as to how cells 
dealt with these crosslinks.  Our assay was able to demonstrate the FANC/BRCA damage 
response pathway is important for dealing with formaldehyde-induced DNA damage. 
 Finally, we turned our attention to help clarify the type of DNA damage induced 
by hexavalent chromium whose inorganic salts are known cancer inducers but for which 
the mode of action is controversial.  We were able to provide valuable information 
concerning the cellular response to chromate by showing that chromate probably induces 
mutagenicity by interfering with replication but not through oxidative stress.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 iv
ACKNOWLEDGEMENTS 
 
 To complete a project on the scale of a doctoral dissertation, especially in science, 
requires the support of quite a number of people. From my doctoral committee and 
advisor to the Department of Environmental Sciences and Engineering to administrators, 
my laboratory mates, family and friends and many others – I am truly indebted.  
Specifically, I first wish to acknowledge my advisor, Dr. Jun Nakamura, who accepted 
me into the program and without whose knowledge and guidance I would have been 
utterly lost.  His tirelessness and wisdom are assets that make him not only a superb 
researcher but an exceptional teacher and advisor.  Secondly, I must thank Dr. James 
Swenberg, who provided the resources and guidance without which this project would 
have been impossible.  Next, my gratitude to Dr. Louise Ball is at least equal to any other.  
Dr. Ball was instrumental in my original acceptance to the graduate school and has been 
incredibly supportive throughout my stay here.   Her door has always been open and her 
wit and wisdom have always been sharp.  Another whose door has always been open is 
Dr. Avram Gold, whose insight and support have been indispensable throughout both my 
Master’s and Doctoral programs.  Rounding out those on my committee is Dr. Paul 
Chastain whose guidance in the laboratory and knowledge of DNA metabolism, which he 
was eager to share, kept me on the proper track at times when I was straying.  I next wish 
to thank all of my laboratory colleagues – April Luke, Brian Pachkowski, Kun Lu, Lina 
Gao, Narisa Bordeerat, Sujey Carro, Leonard Collins, Valeriy Afonin, who not only 
 v
impart their knowledge and expertise but are there to share joys, satisfactions, 
disappointments and to just commiserate with when events go wrong.  Of course, the 
laboratory could not function at all if it were not for Pat Upton who I particularly want to 
acknowledge.  Lastly, and most importantly, I want to thank my wife, Alice who has 
sacrificed so much at a time in life when one would hope to be able to slow down a bit 
and enjoy the fruits of past labors.  I cannot hope to ever make up for the lost vacations, 
the improvements to the house and many other wished-for things that have not been 
possible because of this venture I have chosen to undertake.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 vi
TABLE OF CONTENTS 
 
LIST OF TABLES………………………………………………..………………....…...xii 
 
LIST OF FIGURES…………………………………………………….……………….xiii 
 
LIST OF ABBREVIATIONS............................................................................................xv 
 
Chapter 
 
 1.   Introduction……………………………………………………………….….1 
 
  DT40 Cell System………………………………………………………...2 
 
  Characteristics of DT40 Cells and Cells Utilized for Other   
  Genotoxicity Analyses……………………………..……………….…….3 
   
   Ames test…………………………………………………………..3 
 
   Yeast assay………………………………………………………...4 
 
   Murine ES cells……………………………………………………6 
 
  Applicability of DT40 Cell System toToxicology Studies……..….……8 
 
  Significance……………………………………………………………...11 
 
  Specific Aims……………………………………………………………12 
 
  Specific Aim 1:  Establishment of a convenient DNA damage 
  response assay using the DT40 cell system…………………………...…13 
 
  Specific Aim 2:  To determine, using the DT40 cell system, 
  the mechanism by which DNA-protein crosslinks induced by   
  formaldehyde are repaired………………………………………….……14 
 
  Specific Aim 3:   Analyze, using the DT40 cell system,  
  the DNA damage response to chromium (VI)…………………………...14 
 
 
 vii
2.   Development and Validation of a Multi-well based DT40 Cell 
       Damage Response Assay……………………………………………………18 
 
  Abstract………………………………………………………………….18 
 
  Introduction.………………………………..…………………………...19 
 
   The DT40 cell system……………………………………………20 
   XTT cell proliferation assay……………………………………..22 
 
  Materials and Methods…………….…………………………….……..23 
 
   DT40 cell culturing and maintenance………………...………….23 
 
    Materials…………………………………………………….…23 
 
    Method…………………………………………………...23 
 
   Test Procedure…………………………………………………...25 
 
    Materials…………………………………………………25 
 
    General Method………………………………………….25 
 
    Test with Cisplatin……………………………………….27 
 
    Test with Acrolein…………………………………….….27 
 
    Statistical Methodology Development…………………...27 
 
     Model the relation between treatment  
     Dosage and survival proportion………...….…….27 
 
     Trend test of the dose-response relations………...28 
 
     Minimum effective dose…………………………29 
 
     Difference across cell lines………………………29 
 
  Results and Discussion………..………………………………………...30 
 
   Reproducibility and sensitivity in the DT40 cell DNA  
   damage response analysis using the XTT method……………….30 
 
 viii 
   Comparison of cisplatin exposure results between 
   the DT40 XTT dye and clonogenic methods……………….……31 
    
    Cisplatin………………………………………………….31 
 
    Acrolein…………………………………………………..32 
 
    Acrolein Results………………………………………….34 
 
   Advantages of the XTT dye method over the clonogenic 
   Method……………….……...……………………………….…..36 
 
 3.   Use of the DT40/XTT Assay in the Determination of the DNA 
       Repair Pathway Responsible for the Tolerance of Formaldehyde 
       Genotoxicity…………………………………...…………………………….43 
 
  Abstract……………………………………...…………………………..43 
 
  Introduction……………………………………..………………………44 
 
  Materials and Methods…………………………….…………………...46 
 
   Materials…………………………………………………………46 
 
   Cell lines and culture…………………………………………….46 
 
   Cell survival assay……………………………………………….47 
 
   Determination of intracellular total GSH…………………….…..47 
 
   Statistical analysis…………………………………………….….48 
 
  Results and discussion……………………………………………...…..48 
 
   HR repair and NHEJ repair of DNA damage induced 
   by formaldehyde…………………………………………………48 
 
   Role of excision repair pathways in the repair of DNA 
   damage induced by formaldehyde……………………………….49 
 
   Role of translesion DNA synthesis and cell-cycle 
   checkpoint pathways in the repair of DNA damage 
   induced by formaldehyde………………………………………..50 
 
    
 
 ix
   Role of FANCD2 in the repair of DNA damage  
   induced by endogenously existing aldehydes other than   
   formaldehyde…………………………………………………….51  
    
   Endogenous DPC-inducing agents and Fanconi 
   Anemia…………………………………………………...………51 
 
   Possible DNA repair pathways for DPCs induced 
   By formaldehyde…………………………………………………52 
 
 4.   Use of the DT40 Cell System for the Determination of the DNA 
       Repair Pathway Responsible for the Tolerance of Hexavalent  
       Chromium Genotoxicity……………………………………………………61 
 
  Abstract………………………………………………………………….61 
 
  Introduction..............................................................................................62 
 
   Exposure to hexavalent chromium……………………………….62 
   Absorption, distribution, metabolism and excretion 
   of hexavalent chromium……………………………...……….…65 
 
   DNA damage induced by chromium.............................................67 
 
  Materials and Methods……………………………………...………….70 
 
   Cell culture……………………………………………………….70 
 
   DT40 multi-well survival assay.....................................................71 
 
   Larger-scale exposure method……………….…………………..71 
   DNA extraction……………………………….………………….72 
   Potassium chromate acute toxicity analysis in  
   DT40 cells………………………………………………………..72 
 
   Assay for level of 8-oxo-dG……………………………………..73 
   Glyoxal Gel Electrophoresis…………………………………….74 
   OTX-AGE electrophoresis………………………………………75 
   DT40 DNA fiber spread analysis………………………………..76 
 x
    Cell preparation and treatment………………………….76 
    DNA Fiber Spread Analysis……………………………..76 
   Determination of intracellular NAD(P)H after 
   treatment with potassium chromate……………………………..77 
 
   Statistical analysis……………………………………………….78 
  Results and Discussion…………………………………………………78 
   Role of homologous recombination repair and 
   non-homologous end-joining repair of DNA  
   damage induced by potassium chromate………………………..78 
 
   The contribution of the excision repair  
   (BER/NER) pathways to the repair of DNA  
   damage induced by potassium chromate………………………..79 
 
   Result of acute toxicity test of DT40 parental 
   cells exposed to potassium chromate……………………………81 
 
   The role of oxidatively induced genotoxicity  
   due to exposure to Cr(VI) in DT40 cells…………………….…..81 
 
    Result of 8-oxo-dG assay after exposure 
     to chromate………………………………….……….….83 
     
    Result of NAD(P)H depletion assay for SSB…………….83 
    Result of GGE assay for SSB…………………………….84 
    Result of OTX-AGE assay for SSB………………………85 
   Result of DNA fiber spread analysis of DNA exposed 
   to potassium chromate…………………………………………...85 
 
   Discussion………………………………………………………..87 
 5.   General Discussion…………………………………………………......….102 
  Summary and Conclusions…………………………..…………...…..102 
  Future Directions………………………………………………….......105 
 Appendix…………………………………………………………………….…108 
 xi
  Appendix A. Statistical Analysis……………………………………...108 
 References……………………………………………………………………...115 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xii
LIST OF TABLES 
 
Table 
 
 1.1.   Example of Available DT40 Mutant Cell Lines…………………………..16 
 
 1.2.   Species Comparison of DNA Repair Pathways…………………………...17 
  
 2.1.   Format for Treatment of 24-well plate…………………………...………..41 
 
 2.2.   Comparison of Clonogenic Method to XTT Dye Method…..…………….41 
 
 A.1.  Contingency table comparison of the MED estimated from our  
parametric approach…………………………………………………......111 
 
 
 
 
   
 
    
 
 
  
 
 
 
     
 
 
 
 
 xiii 
LIST OF FIGURES 
 
Figures 
 
 2.1.   XTT metabolization to formazan salt…………………………………….37 
 
2.2.   Protocol overview of XTT-based DT40 cell DNA damage  
 response analysis  using 24-well plate format……………….…………..37 
 
2.3.   Cell survival results for DT40 cells and POLB mutants 
 continuously exposed MMS…..................................................................38 
. 
 2.4.   Cell survival results for DT40 cells and their isogenic mutants  
continuously exposed to cisplatin………………………………………..39 
 
 2.5.   Reactions of acrolein with deoxyguanidine…………………….…….…..40 
 
 2.6.   Cell survival results for DT40 cells and their isogenic mutants  
 continuously exposed  to acrolein………………………………………..40 
 
 3.1.   Formation of DNA-protein cross-link with formaldehyde………….……54 
 
 3.2.   Relative LC50 values and linear regression analysis cell survival  
 results in DT40 cells and their mutants exposed to formaldehyde………55  
 
 3.3.   Sensitivity of wild-type (wt) and HR- and NHEJ- deficient 
cells after exposure to formaldehyde…………………………………….56 
 
3.4.   Sensitivity of wild-type (wt) and BERNER, TLS and Cell 
 Cycle Checkpoint-deficient cells after exposure to formaldehyde…..…..56 
 
3.5.   Sensitivity of DT40 cells and DT40-derived FANCD2  
 deficient cells to aldehydic agents……………………………………….57 
 
3.6.   Sensitivity of parental RKO cells and their isogenic FANCC-/-/- 
  and FANCG-/- cells after exposure to formaldehyde……………………58 
  
3.7.   Hypothesized pathway for the repair of DPC……………………………59 
 
4.1.   Forms of chromium(VI) in aqueous solution…………………………….90 
 
4.2.   Major steps in the uptake, metabolism and formation of DNA  
 damage caused by Cr(VI)………………………………………………..90 
 
4.3.   Putative Asc-Cr-DNA ternary adduct…………………………………….91 
 
 xiv
4.4.   Formation of microchelate adducts of Cr(III) with DNA…………..…..….91 
 
4.5.   Relative LC50 values of cell survival results in DT40 parental 
 and HR or NHEJ mutant cells exposed to potassium chromate…………..92 
 
4.6.   Relative LC50 values of cell survival results in DT40 parental 
 and BER or NER mutant cells exposed to potassium chromate……….….92 
 
4.7.   Result of 4-hour continuous exposure of parental DT40 cells  
 to the indicated Cr(VI) concentration………………………………….….93 
 
4.8.   Result of assay to determine level of 8-oxo-dG due to exposure 
 to potassium chromate…………………………………………………….94 
 
4.9.   Result of NAD(P)H depletion assay performed with DT40 
 parental cells………………………………………………………………95 
 
4.10.  Result of GGE SSB assay for DT40 parental cells exposed 
 to 0, 30 and 60 uM potassium chromate for 4 h…………………………..95 
 
4.11.  Result of OTX-AGE SSB assay for DT40 parental cells  
 exposed to 0, 30 and 60 uM potassium chromate for 4..………………….96 
 
4.12   OTX-AGE Assay of Chromate Exposure....................................................96 
 
4.13.  Detection of DNA replication tracks…………………………………...…97 
 
4.14.  Visualization of replication using DNA combing………………………...97 
 
4.15.  Chromium Slightly Increases Terminations………………………………98 
 
4.16.  Chromium Alters Origin Initiation………………………………………..98 
 
4.17.  Effect of chromate exposure on replication rate in wt DT40 cells………..99 
 
4.18.  Proposed and reported possible types of DNA damage induced by 
hexavalent chromium………………………………………………….…100 
 
A.1.   Parametric fit of the relation between Acrolein dosage and  
 survival proportion…………………………………………………….....108 
 
A.2.   The 95% prediction CIs of the difference between different  
 cell lines and cell line DT40…………………………………………..…112 
 
 
 xv
List of Abbreviations 
 
 
3-AB  3-aminobenzamide 
8-oxo-dG 8-oxo-2'-deoxyguanosine 
Acr  acrolein 
α-HOPdG α-hydroxypropano-deoxyguanosine 
ANOVA analysis of variance 
APE  apyrimidinic/apurinic endonuclease 
ATM  ataxia telangiectasia mutated 
ATR/ATRIP ATM and Rad3 related/ATR-interacting protein 
BER  base excision repair 
BLM  Bloom’s helicase 
BRCA1 breast cancer 1 
BRCA2 breast cancer 2 
BrdU  bromo-deoxyuridine 
CldU  chloro-deoxyuridine 
Cr(III)  trivalent chromium 
Cr(VI)  hexavalent chromium 
DAC  DNA-amino acid crosslink 
dG  deoxyguanosine 
DMSO  dimethyl sulfoxide 
DPC  DNA-protein crosslink 
DSB  DNA double-strand break 
dsDNA double-strand DNA 
 xvi
FANCD2 Fanconi anemia complementation group protein D2 
ES  embryonic stem  
FA  Fanconi anemia 
FBS  fetal bovine serum 
FEN1  flap endonuclease 1 
γ-HOPdG γ-hydroxypropano-deoxyguanosine 
GGE  glyoxal gel electrophoresis 
GSH  glutathione 
HR  homologous recombination 
IARC  International Agency for Research on Cancer 
ICL  DNA interstrand crosslink 
IdU  iodo-deoxyuridine 
LC50  50% lethal concentration 
MED  minimum effective dose 
MMR  mismatch repair 
MMS  methyl methanesulfonate 
MOA  Mode of Action 
NER  nucleotide excision repair 
NHEJ  non-homologous end-joining 
OTX-AGE O-(tetrahydro-2H-pyran-2-yl)hydroxylamine agarose gel electrophoresis 
PAR  polymeric adenosine diphosphate-ribose 
PARP1 poly [ADP-ribose] polymerase 1 
PBS  phosphate buffered saline 
 xvii
PCNA  proliferating cell nuclear antigen 
PMS  phenazine methosulfate 
POLB  DNA polymerase β 
POLH  DNA polymerase η 
POLK  DNA polymerase κ 
ROS  reactive oxygen species 
Sp  spiroiminodihydantion 
SSB  DNA single-strand break 
TEMPO 2,2,6,6-tetramethylpiperidine-N-oxyl 
TLS  translesion synthesis 
XPA  xeroderma pigmentosum complementation group A protein 
XRCC2 X-ray repair cross complement protein 2   
XTT  2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]- 
  2H-tetrazolium hydroxide 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Chapter 1.     Introduction 
 
Every year, a large number of new chemicals (~2000) are being added to the 
already vast list (~80,000) that exists.  Therefore, there is a growing need to be able to 
quickly establish the potential dangers of these compounds in terms of genotoxicity, 
mutagenicity and carcinogenicity.   To this end a number of procedures have been 
developed, such as the Ames test, the yeast reverse-genetic assay, various in vitro cell-
based assays and a variety of animal studies.  Each has its value but, unfortunately, they 
all have shortcomings, such as false negatives, false positives, lack of sensitivity or lack 
of an adequate correlation to humans that can muddle the decision making process for 
producers and regulators.  Also, some of these methods are quite time consuming and/or 
expensive.  Therefore, it is clear that any new assay providing additional information 
regarding how cells respond to exogenous agents and that could improve upon any or 
most of these weaknesses, whether it is with greater accuracy, higher sensitivity, better 
applicability to humans, higher throughput or lower cost, should be greatly welcomed. 
In the field of toxicology, the use of biomarkers has been rapidly gaining in 
importance.  Once one better understands the mode of action of the target compound and 
which DNA repair pathway is needed to alleviate the any DNA damage induced, the type 
of biomarker required tends to be more easily determined.  Without such information, 
biomarkers are sometimes being established without knowledge of whether the target is 
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biologically important.   Genotoxicity and the mechanism thereof may be indirectly 
inferred from knowledge of which DNA metabolic (repair, cell cycle checkpoint and/or 
damage sensing) pathway(s) is involved in the alleviation of the damage.  In an attempt to 
clarify the metabolic mechanisms used to repair DNA damage induced by exogenous and 
endogenous agents this project has made extensive use of the chicken DT40 cell system 
and the great number of DNA repair, cell-cycle checkpoint and DNA damage sensing 
mutants that have been created. 
  
DT40 Cell System 
The reverse genetic approach provides a powerful method for the study of gene 
function and regulation.  One such approach which has been gaining in popularity makes 
use of the isogenic DT40 cell line with its dozens of mutants for many cellular metabolic 
pathways including all known DNA repair pathways, as well as the cell cycle checkpoint 
and DNA damage sensing mechanisms (Table 1.).  
   DT40 cells originated from a chicken B-lymphocyte line derived from an avian 
leucosis virus induced bursal lymphoma originally isolated in 1985 (Baba et al., 1985).  
The DT40 cell line is rather unique in that it exhibits a high ratio (targeting efficiency 10 
– 90%) of targeted to random integration of transfected DNA, whereas most transfected 
DNA integrates at random chromosomal positions in mammalian cells (targeting 
efficiency in mouse ES cells: 0.1 – 5%) and those of other higher eukaryotes (Sonoda et 
al., 2001; Dhar et al., 2001). This high targeting efficiency allows for the production of 
double and even triple mutants with relative ease where multiple mutations are virtually 
impossible at the lower efficiencies of the other commonly used cell lines.  DT40 cells 
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also exhibit an exceptionally stable karyotype with very low levels of spontaneous 
chromosomal aberrations which allows for culturing of the cells for extended periods free 
from concern regarding variance in their genetic character (Hochegger and Takeda 2006).       
Another unique feature of the DT40 cells is their reported lack of functional p53 
(Takao et al., 1999).  When testing a DNA repair mutant with a functioning p53 protein, 
general genomic instability may cause the cell to die due to the activation of apoptosis. 
The absence of functional p53 in DT40 cells presents the advantage of a compromised 
apoptosis pathway allowing for the observance of cell death due to defect-driven repair 
failures rather than by the activation of apoptosis (Hochegger and Takeda, 2006).  
Due to the facility with which the DT40 line can be manipulated genetically, and 
the fact that DT40 mutants are observed to show a strong phenotypic resemblance to 
murine mutants with respect to genes involved in DNA recombination and repair 
(Winding and Berchtold 2001), the line has seen a steady growth of its use in genetic 
studies including immunoglobulin diversification, DNA repair, chromosome segregation, 
RNA metabolism and cell signaling (Winding and Berchtold, 2001; Yamazoe et al., 
2004; Dhar et al., 2001). 
 
Characteristics of DT40 Cells and Cells Utilized for Other Genotoxicity Analyses 
 
Ames test 
 The Ames test is a bacterial reverse-mutation assay designed as a screen to detect 
the genotoxicity of chemicals.  Salmonella strains deficient in their ability to produce 
histidine are exposed to chemicals and mutagenicity is determined by the cells’ reversion 
to a wild type phenotype which is histidine-independent due to mutations caused by the 
chemical under test (Maron and Ames, 1983).  However, although the Ames test achieves 
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a good association with animal carcinogenicity results, it is known that a great many of 
the enzymes that are used by humans (nearly all of which have homologs in DT40 cells) 
in DNA repair pathways simply are not known to exist in bacterial cells. Prime examples 
would be the DT40/human BER proteins, polymerase β (POLB) and poly [ADP-ribose] 
polymerase 1 (PARP1), for which no equivalents have been found in bacteria.  Added to 
this can be HR, for which there are numerous proteins involved in vertebrate cells which 
do not exist in bacterial cells and the pathways are thought to operate in a very different 
manner (Friedberg et al., 2005).  Finally, it has been recognized that Salmonella most 
likely lack the non-homologous end-joining pathway used by eukaryotes (and some other 
prokaryotes) as an alternative to HR in the of repair DNA double-strand breaks (Bowater 
et al., 2006). 
 
Yeast assay  
 The use of mutant yeast strains has for decades been one of the mainstays of 
reverse genetic studies.  However, yeasts have been found to be more tolerant to repair 
and cell-cycle checkpoint defects than higher eukaryotic cells (Dhar et al., 2001) leading 
to the possibility of underestimation of sensitivity in cell death experiments.  This is 
perhaps due, at least partly, to the difficulty certain chemicals have in crossing the less 
permeable cell membrane of yeast cells.  It has been recognized that there is a high level 
of homology between yeast genes and those of mammalian cells; whereas, function of 
some of the DNA damage response genes appears to be different. For example, Rainey, 
et al., have reported that Chk1 and Chk2 knockouts in DT40 showed that these 
checkpoint effector kinases control a very different range of checkpoint responses in 
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vertebrates compared with yeast (Rainey et al., 2006).  Also, homology between yeast 
genes and those of mammalian cells and DT40 cells do not necessarily indicate the same 
mechanism in their associated pathways (Table 2.) (Sonoda et al., 2001).  Furthermore, 
the relative role of each DNA repair pathway observed in yeast and vertebrate cells 
appears to differ (Yamazoe et al., 2004).  For example, homologous recombination (HR) 
repair in yeast functions at any time during the cell cycle, whereas HR in vertebrates is 
only active during late S-phase to G2 (Takata et al., 1998).  Thus, the overall relative 
contributions of HR and non-homologous end-joining (NHEJ) to DNA double-strand 
break (DSB) repair show a considerable variance between S. cerevisiae and mammalian 
cells with DSBs being repaired mainly through HR in the yeast while NHEJ plays only a 
minor role (Aylon and Kupiec, 2004; Lee et al., 1999).  Critchlow and Jackson have 
reported that, in mammalian cells, NHEJ appears to be of greater importance (Crithchlow 
and Jackson, 1998), while another report indicated it is responsible for repairing more 
than 60% of exogenously induced DSBs in mouse embryonic stem cells (Liang et al., 
2006).  In fact, genes required for HR, such as Rad51 or Rad54, are not expressed in 
quiescent vertebrate cells after insult by genotoxic agents (Tan et al., 1999) so that non-
homologous end joining (NHEJ) would be the pathway of choice, whereas yeast could be 
using HR. Also, another important category of proteins, the Fanconi anemia 
complementation group (FA), which are involved in HR and DNA replication control in 
mammalian cells, are, with a few exceptions absent in yeast (Errico and Costanzo, 2010).   
Furthermore, vertebrate proteins directly involved in DSB repair also stimulate a cell-
cycle checkpoint, and conversely, proteins involved in checkpoints promote DNA repair, 
whereas a checkpoint defect does not affect repair in yeast (Sonoda et al., 2001).   
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 The base excision repair (BER) pathways in mammalian and yeast cells exhibit 
many disparities (Kelley et al., 2003).  For instance, the apyrimidinic/apurinic nucleases 
(APE) are different proteins and function differently in mammals and S. cerevisiae.  In 
fact, murine blastocysts knocked out in APE, as well as human antisense-expressing cells, 
are hypersensitive to γ rays and oxidizing agents such as H2O2, whereas yeast cells 
deficient in Apn1 (the protein which functions similarly to APE in yeast) showed only 
mild sensitivity at best (Evans et al., 2000).  Yeast cells also lack some of the enzymes 
for dealing with 8-oxo-2'-deoxyguanosine (8-oxo-dG; i.e., MYH, MTH), enzymes that 
exist in mammalian cells (Kolodner and Marsischky, 1999).  Therefore, in yeast, adenine 
which has been mispaired with 8-oxo-dG is most likely removed by the mismatch repair 
machinery rather than BER.  Also, yeast cells contain no equivalent proteins to POLB or 
PARP1, both of which are used in vertebrate cells in BER (Friedberg et al., 2005).  As a 
result, yeast perform primarily long patch BER, whereas vertebrates use mainly short 
patch BER (Kelley et al., 2003). In summary, it seems evident that vertebrate cells such 
as the DT40 line, which exhibit a much more comparable homology to those of mammals 
in many DNA metabolic proteins, provide an advantage over yeast in the examination of 
DNA repair pathways as well as cell cycle checkpoints. 
 
Murine ES Cells      
Although many gene-targeting experiments have been performed using 
mammalian cells, the approach has been hampered by low efficiencies (10-2 to 10-5) in 
the integration of exogenous DNA through HR, as most of the DNA integrates at random 
positions on the chromosomes (Sonoda et al., 2001).  In 1991, Buerstedde and Takeda 
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found that targeted integration frequencies in DT40 cells far exceeded those of random 
integration (more than 1:2) and were orders of magnitude higher than the frequencies in 
mammalian and other higher eukaryotic cells (Buerstedde and Takeda, 1991). For 
example, DT40 cells have 15 to 100 times greater targeting efficiency than murine 
embryonic stem (ES) cells (Dhar et al., 2001).  As such, to detect one targeting event only 
10-50 DT40 colonies need be screened in comparison to 100-1000 colonies for the mouse 
cells.  The low gene-targeting efficiencies of ES cells also make it nearly impossible to 
produce double or triple mutants in those cells where it is relatively easy in DT40 cells.  
Also, many murine knockouts in recombination and DNA repair processes cause 
genomic instability with damage checkpoint stimulation.  This genomic instability leads 
to a loss of viability of both the fetus and cultured cells making the cells of little use in 
the analysis of chromosomal processes because of their limited growth (Yamazoe et al., 
2004).  Furthermore, Sale reports that knockouts for HR proteins are embryonic lethal in 
mice (Sale, 2004), and, as this is not the case for most DT40 recombination knockouts, 
the DT40 cells possess a distinct advantage when investigating HR repair. 
Many different knock-out mouse embryonic fibroblasts are available for 
genotoxicity testing.  However, the different knock-outs are from various strains of mice 
which can make comparisons of responses to potential mutagens somewhat more difficult.  
Alternatively, all DT40 mutant cell lines have originated from a single parent and are 
therefore isogenic.  This allows for very precise comparisons between responses to DNA 
damaging agents.   
 Another advantage of DT40 cells is their inherent ability to maintain a stable 
karyotype which makes them particularly valuable in assessing the effect of mutagenic 
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compounds.  In contrast, murine ES cells tend to lose multipotency upon exposure to 
such mutagens (Dhar et al., 2001).  
 Finally, extensive work has been performed comparing the phenotypes of murine 
and DT40 cells with little difference found between the two.  This has allowed for a 
favorable and widespread reception for the use of DT40 cells in reverse genetic 
investigations. 
 
Applicability of DT40 Cell System to Toxicology and Genotoxicity Studies 
 
   In the field of toxicology, the use of biomarkers has been rapidly gaining in 
importance.  Once one knows the DNA damage response to the target compound and 
which DNA repair pathway is needed to alleviate the damage, the type of biomarker 
required can be more easily determined.  For example, if hypersensitivity is detected in 
cells that are deficient in BER, then one could focus on N7-alkylation adducts as 
biomarkers of exposure to ethylene oxide or propyrene oxide.   
 In an attempt to illuminate the mechanisms used to repair DNA damage induced 
by exogenous and endogenous agents, this project has made extensive use of the DT40 
system and the great number of repair and cell-cycle checkpoint mutants that have been 
created.  This project has also endeavored to improve upon the methodology currently 
being used with DT40 cell assays.  Presently most, if not all, researchers making use of 
the DT40 cell line are performing their tests using the clonogenic method and growing 
the cells in a methylcellulose gel (Simpson and Sale, 2006).  Although the clonogenic 
method is certainly highly regarded for its accuracy and sensitivity, for the purpose of 
screening scores of chemicals it has the drawback of being overly time consuming and 
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costly.  Also, there is a very real possibility that the methylcellulose may react with some 
chemicals one may wish to test, thus limiting the value of the assay. In fact, it appears 
that the subject of Specific Aim 2 of this project, formaldehyde, may be such a case.  
Here, the intent was to develop a novel (in the case of DT40 cell assays) micro-plate 
based assay for use with these cells that will be as accurate and sensitive as the 
clonogenic method but have the advantages of much higher throughput, reduced 
manipulation and greatly reduced cost.  This new procedure has made use of the 
compound 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-
tetrazolium hydroxide (XTT) by which one may measure cell viability based on the 
activity of mitochondrial enzymes in live cells that reduce XTT but are inactivated 
shortly after cell death. The XTT is reduced to a formazan dye with specific absorbance 
at 450 nm.  The percent survival can then be easily and accurately determined by 
comparison of absorbance measurements of test samples to those of controls. This 
method produces results in days instead of weeks with a dramatic reduction in materials 
used and much less manipulation by laboratory personnel.  The method development has 
used cisplatin as one model for verification of the assay.  Cisplatin was chosen because 
there is existing data obtained from DT40 mutants using the clonogenic assay (Takata et 
al., 1998; Nojima et al., 2005; Matsushita et al., 2005).  Our cisplatin results coincide 
quite well with those of studies using the clonogenic assay.  To further verify the assay, 
attention was then turned to acrolein, a highly reactive α,β-unsaturated aldehyde, as it has 
been the object of numerous studies over a relatively long period and although it is 
known to be involved in DNA adduction, there is still controversy concerning its 
mutagenicity and carcinogenicity in humans (Minko et al., 2009; Stevens and Maier, 
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2008).  Our work here has indicated a virtually complete agreement with the studies of 
others that have shown sensitivity to acrolein in translesion DNA synthesis deficient cells 
but generally very little sensitivity in cells deficient in other DNA metabolic pathways, 
thus providing another verification of the accuracy of our DT40 assay (Kanuri et al., 
2002; Minko et al., 2003).   
 In specific aim two, the focus was turned to formaldehyde – another highly 
reactive aldehyde that has recently been listed as a known human carcinogen by the 
International Agency for Research on Cancer (IARC) (Cogliano et al., 2005).  
Formaldehyde is a ubiquitous environmental pollutant found in automobile exhaust and 
tobacco smoke, among many other indoor and outdoor sources for which humans are 
known to be exposed (Cogliano et al., 2005).  There also exists an endogenous exposure 
to formaldehyde as it is present in significant concentrations in all tissues, cells and 
bodily fluids (Szarvas et al., 1986; Heck and Casanova, 2004).  Formaldehyde has been 
shown to induce DPC but very little has been learned as to how the cell deals with these 
lesions in terms of tolerance and repair.  The DT40 system, with cell lines deficient in 
every known DNA repair pathway, has provided an excellent approach for the 
determination of the mechanism(s) used by cells for dealing with DNA-protein crosslinks 
(DPC) caused by formaldehyde (Ridpath et al., 2007). 
 In order to demonstrate the versatility of this high-throughput genotoxicity assay 
using the DT40 cell system we chose to use the system for the study of an inorganic 
toxicant.  Thus, the highly toxic and carcinogenic metal chromium (hexavalent) was the 
focus of specific aim three of this project.  Chromium is a naturally occurring element 
found in rocks, animals, plants and soil and can exist in all three physical forms – liquid, 
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solid or gas. The most important valence states of chromium to which humans are 
exposed are the tri- and hexavalent forms (Cr[III] and Cr[VI]) (P.H.S. US Department of 
HHS, Agency for Toxic Substances and Disease Registry Toxicological Profile for 
Chromium, Sept. 2000).  While extracellular Cr(III) is somewhat toxic, it is absorbed 
very poorly by cells and is not considered to possess great significance as an exogenous 
human toxicant.  However, quite the opposite is the case with Cr(VI) which is readily 
taken up by cells after which it is rapidly metabolized to Cr(III) which, intracellularly, is 
the toxic and carcinogenic state of the element (O’Brien et al., 2003; Zhitkovich, 2005; 
Salnikov and Zhitkovich, 2008; McCarroll et al., 2009).  Therefore, exogenous exposure 
to Cr(VI) has been focused on here. As with acrolein and formaldehyde, the new DT40 
method developed in this project will be used in this genotoxicity study of chromium. 
 
Significance 
 When regulatory bodies are determining the potential carcinogenicity of a 
chemical one of the most integral aspects in evaluating the Weight of Evidence is to 
ascertain if the chemical is mutagenic and, if so, what is the mechanism of that 
mutagenicity.  In the U.S. EPAs document, Framework for Determining a Mutagenic 
Mode of Action for Carcinogenicity: Using EPA’s 2005 Cancer Guidelines and 
Supplemental Guidance for Assessing Susceptibility from Early-Life Exposure to 
Carcinogen, it states that “No single mutagenicity test is able to detect the entire 
spectrum of induced mutagenic events.”  While the DT40 test system developed in this 
project likewise would not be able to detect the ‘entire spectrum of mutagenic (or 
genotoxic) events’, it is believed that the ability, with this system, to determine the 
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distinct DNA repair pathway involved will provide additional information when used 
along with genotoxicity assays.  Also, the applicability of this assay to be further 
developed into a truly high-throughput method may one day enhance any regulatory 
body’s ability to react faster to the appearance of new chemicals to be evaluated or to a 
perceived necessity to re-evaluate an existing agent. 
  
Specific Aims  
Humans are exposed to a prodigious number of exogenous carcinogens in daily 
life.  While an extraordinary amount of research has been done to identify which 
chemical agents induce cancer, very little, in most cases, is known of the modes of action 
of these compounds.  However, determination of the mode of action can be very 
advantageous in determining biomarkers of effect which may lead to increased ability to 
prevent the deleterious actions of these chemicals.  In addition, since a very great number 
of these compounds induce cancer by causing DNA damage with resulting heritable 
mutations, the aspect of the mode of action involving DNA repair mechanisms has gained 
increasing importance.  The mechanisms used to cause DNA damage are known for only 
a very limited number of these chemicals.  At present, the methods available for the 
determination of these DNA damage modes of action are time consuming, expensive and 
are either not sensitive or specific enough or involve the use of animal subjects that is 
becoming more and more unpopular.  Therefore, the goal of this project has been to 
develop a simple, convenient and cost efficient method to measure the DNA damage 
response to exogenous agents and to provide strong evidence that the system is sensitive 
and accurate enough to more precisely understand mechanisms of the DNA damage 
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response at concentrations that are relevant to those measured in humans and to current 
regulations. 
 
Specific Aim 1:  Establishment of a convenient DNA damage response assay using the 
DT40 cell system. 
 
While there are certainly existing methods for the determination of which DNA 
repair mechanisms are concerned with the repair of damage induced by exogenous agents, 
these methods each seem to have shortcomings such as lack of specificity with regard to 
the relevance to mammalian systems.  It was the intent of this aim to develop an 
improved method using the vertebrate DT40 cell line so that DNA repair modes of action 
can be determined with much greater rapidity and less expense than the current methods.    
For this assay, cells were grown in 24-well plates and exposed to serial dilutions of the 
compound of interest.  After a sufficient growth period, the cells were exposed to XTT 
dye, a tetrazolium derivative that is reduced by mitochondrial enzymes only in living 
cells.  Thus, the amount of product generated from XTT reduction is proportional to the 
number of living cells in the sample and can be quantified by measuring absorbance at a 
wavelength of 450 nm.  Survival of mutant cell lines was then compared with that of the 
wild type to determine the sensitivity of the mutant to the compound under test.  By 
collaboration, a statistical test for significance has also been developed.  It was expected 
that cells mutated for proteins involved in the repair pathway that deals with the chemical 
will show greater sensitivity than either the wild type or mutants from other repair 
pathways and that the type of damage induced by the agent will be indicated.   
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Specific Aim 2:  To determine, using the DT40 cell system, the mechanism by which 
DNA-protein crosslinks induced by formaldehyde are repaired. 
 
Formaldehyde has recently (2006) been re-evaluated by IARC as a known human 
carcinogen as a result of studies that found formaldehyde induces nasopharyngeal cancer 
in exposed workers.  While past research has determined that formaldehyde causes 
mutations in DNA by forming DPCs (Hubal et al., 1997), very little is known of the 
process the cell uses to repair these lesions.  This aim also made use of the DT40 cell 
system along with human DNA repair deficient cells to determine which DNA repair 
mechanism(s) are involved in the repair of damage caused by formaldehyde.  Therefore, 
I hypothesized that the reverse genetic approach using the DT40 cell system will 
provide the answer as to which DNA repair mechanism is used to repair DNA-
protein crosslinks induced by formaldehyde. 
 
Specific Aim 3:   Analyze, using the DT40 cell system, the DNA damage response to 
chromium (VI). 
 
Many metal compounds are included among the top twenty most dangerous (to 
humans) environmental chemicals.  One of these metals, chromium – a known human 
carcinogen, seems to have very complex and varied modes of action.  It has been 
suggested that Cr(VI) induces several types of DNA damage including small Cr-DNA 
binary adducts, DNA-Cr-protein crosslinks, DNA-Cr-small molecule ternary adducts, 
DNA damage due to Cr(VI) induced oxidative stress, DNA base damage, DNA single-
strand breaks (SSB) and inter- and intra-strand crosslinks (O’Brien, 2003).  For this aim, 
I hypothesized that by making use of the DT40 cell system to determine damage 
repair responses which can lead to the integration of other assays, valuable 
information can be obtained regarding the mode(s) of action of environmental metal 
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pollutants.  For example, if the repair pathway, base excision repair is found to be 
involved in the response to Cr(VI) exposure, it could be implied that base damage (i.e., 8-
oxo-dG) due to Cr induced reactive oxygen species (ROS) or the oxidation of 
deoxyribose is indicated.  This type of damage is repaired by BER, which, through its 
normal process, creates DNA single-strand breaks.  Therefore, to further investigate, 
DNA single-strand break assays were performed. 
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Chapter 1 Tables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BER NER NHEJ HR 
  - POL β   - XPA   - KU70   - RAD52 
  - FEN1   - XPG   - LIG IV   - RAD54 
  - PARP1    - DNAPKcs   - RAD51c 
DNA damage MMR TLS   - RAD51d 
  sensors   - MSH2   - POL Κ   - XRCC2 
  - RAD9   - MSH3 
  - POL Η   - XRCC3 
  - RAD17   - MSH6   - POL Q   - BRCA1 
Helicase    - REV1   - BRCA2 
  - BLM    - REV3   - FANCD2 
  - WRN    - RAD18  
 
Table 1-1. Example of Available DT40 Mutant Cell Lines
DNA damage repair/tolerance pathways represented: 
BER - base excision repair; NER – nucleotide 
excision repair; NHEJ – non-homologous end-joining; 
HR – homologous recombination; MMR – mis-match 
repair; TLS – trans-lesion synthesis
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Table 1-2.  Species Comparison of DNA Repair Pathwaysa,b 
 
 
a Entries in this table are organized according to DNA repair pathway, indicating functional orthologs.  In many, but not all, cases 
these are also sequence or structural homologs.  
b Dashes indicate that no gene exists.  Blank spaces indicate that the status is unknown. 
 
 
Pathway E.coli S. cerevisiae S. pombe DT40/Human Functional Activity 
BER DNA PolI   Polβ/PolB BER polymerase 
— — — PARP1  
PolA+ RAD27 rad2+ FEN1 5’ nuclease 
NER DNA PolI    Resynthesizes DNA 
 POLδ(POL3) cdc6+ Polδ/PolD Resynthesizes DNA 
 RAD14 rhp14+ XPA Damage verification 
 RAD2 rad13+ XPG 3’ incision nuclease 
uvrA+,uvrB+,uvrC+, 
uvrD+  
 
 
A: Binds damage;  
B: Helicase activity 
C: 3’ and 5’ incision 
D: Helicase activity  
HR recF+,recO+,recR+ 
RAD52 rad22
+
, 
rti1+ RAD52 
Recombination 
accessory factor 
recA +  RAD51 rhp51+ RAD51c Mediates homologous pairing 
 
  RAD51d Mediates homologous pairing 
   XRCC2 HR accessory factor 
   XRCC3 HR accessory factor 
 RAD54 rhp54+ RAD54 Induction of 
supercoiling 
 
  BRCA1 Recombination 
accessory factor 
   BRCA2 Cooperation with Rad51 - essential 
— — — FANCD2 
Chromosomal 
stability, response to 
crosslinks 
NHEJ 
 
YKU70 pku70+ KU70 DNA end binding 
 LIG4  LIG4 Ligation of nick 
TLS 
 REV3 rev3+ REV3 DNA polymerase ζ 
sub-unit 
 RAD18 rhp18+ RAD18 E3 ubiquitin ligase 
dinB+   Polκ/PolK Lesion bypass polymerase 
 RAD30 eso1+ Polη/PolH Lesion bypass polymerase 
   PolQ Lesion bypass polymerase 
MMR mutS+ MSH2 swi8+ MSH2 Mismatch 
recognition 
MSH3 swi4 MSH3 Mismatch 
recognition 
MSH6 
 
MSH6 Mismatch 
recognition 
RECQ 
helicase 
recQ+ SGS1 rqh1+ BLM Resolution of stalled 
replication/helicase 
  WRN 
Resolution of stalled 
replication/helicase/
3’-exonuclease 
CCCP 
 
TEL1 tefu tel1+ ATM Strand break 
sensor/kinase 
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Chapter 2.  Development and Validation of a Multi-well based DT40 Cell DNA 
Damage Response Assay 
 
Abstract 
 Chemists continually synthesize myriad new chemicals (~2000 each year), some 
of which make their way into the environment or otherwise pose possible threats to 
humans who potentially become exposed to the compounds.  Regulators must determine 
whether these, along with the glut (~80,000) of existing, chemicals are toxic and at what 
exposure levels.  An important component of this determination is to ascertain the mode 
of action (MOA) of each compound as it relates to the pathway the compound uses to 
induce genotoxicity.  Several assays have traditionally been used to reveal these effects to 
the genome: the Ames test, tests with yeast and mammalian cell lines, and animal studies.  
Each has its adequacies and weaknesses.  Here, we describe a new multi-well plate-based 
method which makes use of the DT40 isogenic cell line and its dozens of available 
mutants knocked out in DNA repair and cell cycle pathways.  Although the DT40 line 
has existed for some time and has been used in numerous studies of DNA repair 
pathways, little use has been made of this valuable resource for toxicological 
investigations.  Our method dispenses with the clonogenic assay others use with DT40 
cells and introduces the use of the XTT dye scheme for the determination of cell survival 
in a manner that greatly increases throughput and reduces cost while maintaining 
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accuracy and sensitivity.  We believe that this method will be very advantageous if added 
to the repertoire of those investigating MOAs of potentially genotoxic substances.  
 
Introduction 
The specific aim of this section of the project was to develop a new assay for 
which to determine how both endogenous and exogenous agents are damaging DNA.  To 
this end we have melded two systems, the DT40 cell system and the XTT cell 
proliferation assay.  This chapter first describes the approach to the development of the 
method as to the cell maintenance and test procedure processes as well as the 
development, by collaboration, of a statistical test for significance of the difference 
between the results for the wild type versus a mutant cell line.  We then describe 
experiments we performed to demonstrate the reproducibility and sensitivity of the assay.  
In these experiments we exposed DT40 cells to methyl methanesulfonate (MMS) and 
were able to determine excellent reproducibility as well as sensitivity similar to the DT40 
clonogenic assay.   
Next, we undertook to validate the accuracy of our assay.  For this purpose, we 
chose to compare results obtained with our assay to those obtained with the clonogenic 
assay after exposure to cisplatin.  The cell lines chosen were ones which are known to be 
hypersensitive to cross-linking agents, namely Bloom’s helicase (BLM), the X-ray repair 
cross complement protein 2 (XRCC2) and the Fanconi anemia complementation group 
protein D2 (FANCD2).  Another protein, the base excision repair protein, flap 
endonuclease 1 (FEN1), was also chosen as it would be expected to indicate little, if any, 
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sensitivity to cisplatin.  Our results compare very favorably with those of the clonogenic 
assay. 
Finally, as a further verification of the assay, we exposed a representative group 
of the DT40 cell line at our disposal to the highly reactive aldehyde, acrolein.  From the 
results we obtained, we have concluded that acrolein induced DNA damage is primarily 
alleviated by translesion synthesis (TLS).  
          
The DT40 cell system 
As the DT40 cell system has been described in detail in Chapter 1, only a brief 
recapitulation is provided here.  By making use of the DT40 cell line we are using the 
very powerful reverse genetic approach for the determination of the DNA repair 
pathway(s) the cell prefers for the toleration of genotoxicity induced by exogenous and 
endogenous agents.  DT40 cells provide advantages, especially over mammalian cells, 
not found in many other cells lines: 1) they exhibit a high ratio of targeted to random 
integration of transfected DNA which allows for relatively easy creation of double and 
triple mutants; 2) they exhibit an exceptionally stable phenotype and karyotype allowing 
for extended periods of continuous culturing  without concern for genetic drift; 3) they 
have been reported to be deficient in p53 activity leading to reduced apoptosis due to 
genotoxic stress; 4) the cells are maintained in suspension culture making their handling 
much less tedious than that of attached cells; 5) the cell cycle time is much shorter than 
mammalian cells making the cell line more convenient and applicable for high-
throughput screening of potential genotoxic agents; and, 6) approximately 70% of the 
cycle time of DT40 cells is spent in S-phase as the cells are unable to arrest at the G1/2 
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boundary (probably due to the p53 deficiency) (Ji et al., 2009).  This last feature is 
especially interesting because more of the exposed DT40 cells can accumulate is S-phase 
whereas in mammalian cells, even the wild types, may arrest at the G1/S check point for 
up to a few days allowing for complete repair of DNA damage (Bao et al., 2001; Takao et 
al., 1999).  In contrast, DT40 repair mutants can carry even low amounts of DNA damage 
into S-phase where proliferation can be significantly reduced due to interference with 
replication.  The foregoing indicates that a cell proliferation (or survival) assay using 
DT40 cells can be much more sensitive than one using mammalian cells.   
As a result of the advantages of the DT40 cell system, it has been used in 
numerous investigations into various cellular pathways.  In virtually all instances the very 
established clonogenic assay has been employed.  One downside to the method, however, 
is that the cells are usually grown in methylcellulose gel suspension with clonogenic 
assays used to rate cell survival (Simpson and Sale, 2006).  Clonogenic assays are 
considered to be very accurate but are rather tedious.  Indeed, to test just one agent at 
several dilutions along with controls against numerous cell lines could require hundreds 
of dishes with an incredible amount of manual manipulation.  We felt that if the system 
were to be used for screening, a simpler, more rapid and less expensive method would be 
advantageous.  Here, we describe a detailed protocol of a DT40-based response analysis 
that is convenient but still sensitive and precise enough for determining the genotoxicity 
of chemicals by making use of the compound XTT.  
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XTT cell proliferation assay 
 The ability to determine cell proliferation and viability is one of the mainstays of 
many cell biology approaches.  Thus, methods have been developed which are sensitive, 
quantitative and reliable.  Examples of such methods utilize the ability of cells to 
incorporate radioactively labeled compounds such as [3H]-thymidine or to release a 
radioactive isotope 51Cr following cell lysis.  Another example takes advantage of the 
ability of cells to incorporate 5’-bromo-2’-deoxyuridine in place of thymidine which may 
be monitored by immunochemical methods such as the enzyme-linked immunosorbent 
assay (ELISA) or slot-blot assays.  As previously mentioned there is also the clonogenic 
assay.   
 First described by Scudiero, et al., and improved upon by others, the XTT cell 
proliferation assay is a colorimetric method which has no requirement for radioactive 
compounds or immunohistochemical techniques (Scudiero et al., 1988; Weislow et al., 
1989; Roehm et al., 1991).  The method was originally intended for the measurement of 
drug sensitivity in cancer cells (Scudiero et al., 1988). The assay is based on the reduction 
of a yellow tetrazolium salt (XTT) by mitochondrial dehydrogenase to an orange colored 
formazan dye only by metabolically active cells (Fig. 2-1).  Roehm, et al., found that the 
reduction of XTT when used alone in murine cells was not especially efficient but was 
potentiated with the addition of an electron coupling agent such as phenazine 
methosulfate (PMS) (Roehm et al., 1991).  The formazan dye is water soluble and can be 
directly measured with a high degree of accuracy in a spectrophotometric multi-well plate 
reader.  The amount of color developed is directly proportional to the number of living 
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cells in the sample.  This method allows for a much higher throughput with easy on-line 
data collection and processing.  
 
Materials and Methods 
DT40 cell culturing and maintenance 
Materials 
 Fetal bovine serum (FBS), 1-methoxy-5-methylphenazinium methyl sulfate, and 
penicillin/streptomycin were obtained from Sigma (St. Louis, MO).  RPMI 1640 culture 
medium (+glutamine, -phenol red) and chicken serum were acquired from Invitrogen 
(Grand Island, NY). 
 
Method 
 DT40 cells are cultured in a manner similar to most vertebrate or mammalian cell 
lines that are grown in suspension.  Optimal propagation is provided by growing in RPMI 
1640 with 10% FBS, 1% chicken serum and 1% penicillin/ streptomycin.  RPMI sans 
phenol red should be used, as the color in the indicator may interfere during spectroscopy.  
FBS and chicken serum should be heat inactivated at 56 °C for 30 min.  The cells are 
incubated at 39.5 °C and 5% CO2 with 95% humidity.  Since DT40 cells have a relatively 
short generation time (7-10 h), for the sake of convenience we have found that cell 
growth can be slowed by incubation at 37 °C or even as low as 31 °C without undue 
stress to adjust the growth rate during the final 16 h of cultivation.  This process allows 
for the avoidance of overgrowth of the cells.  Also, due to the rapid growth rate, the 
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cultures must be observed regularly to prevent overgrowth with subsequent starvation 
resulting in stress to or death of the cells. 
Sub-culturing should be performed as needed to provide cells in the log phase of 
growth as an optimum test parameter and to maintain cell lines for future use.  For sub-
culture, cells are counted by hemacytometer.  The target cell concentration for both sub-
culturing and the preparation of the cell suspension for the assay that produces the most 
reproducible assay result lies between 0.7x106 and 1.5x106 cells/mL.  Also, cell condition 
should be observed during counting.  Under a light microscope, normal DT40 cells 
appear nearly circular.  Stressed cells may appear elongated or have an uneven margin.  If 
cells appear stressed, it is advisable to newly sub-culture before using in the assay. 
For best results, a certain amount of care should be observed when handling DT40 
cells.  All transfers of cells should be into pre-warmed medium and mixing of the cells 
prior to pipetting should be very gentle but absolutely thorough – especially for cell 
counts or seeding for an assay.  It is also advisable to use pipette tips with large bore 
openings such as those used in genomic studies.  Our results and reproducibility 
improved notably with the use of these procedures. Indeed, our success rates using the 
assay had been very wide-ranging (from 1 to 70%) using our previous method (Ridpath et 
al., 2007); whereas, the current improved method provides a success rate of nearly 100%. 
Although DT40 cells are considered immortal, each cell line should be restarted 
from frozen stock about once each month.  Considering that most of our cell lines are 
deficient in DNA repair, this seems an appropriate choice.  The cells can readily be stored 
under liquid nitrogen for extended periods. 
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Test procedure 
Materials 
 Cisplatin, MMS, XTT, PMS and dimethyl sulfoxide (DMSO) were obtained from 
Sigma (St. Louis, MO).  
 
General Method  
 The overall scheme of this assay is shown in Figure 2-2. Cells are prepared in 
sterile centrifuge tubes by adding enough volume of cell-containing medium from the 
sub-culture dish to 6 mL warmed fresh medium to provide a cell concentration adequate 
to seed approximately 2500 cells in a volume of 250 µL to each of 22 wells.  Before 
seeding, the cells should be adequately but gently mixed in the tubes. The cells are then 
seeded by pipetting 250 µL of the cell suspension to each of 22 wells of the 24-well plate 
(Table 2-1).  To the two blank wells add 250 µL plain medium.  These plates should be 
kept in an incubator at 39.5 oC until ready for treatment with the chemical compound(s).  
This method provides for treatment with six dilutions of the chemical, each into three 
wells, with four untreated wells as controls and two as blanks (Table 2-1).  Treatment is 
performed by adding 27.8 µL (total well volume, 277.8 µL) of the chemical dilution to 
each appropriate well and 27.8 µL of the chemical solvent - usually either phosphate 
buffered saline (PBS) or DMSO - to the control and blank wells.  The plates are returned 
to the incubator.    
Once treated, the incubating cells should not be disturbed for 48 hr after which 
they should be observed microscopically to determine the growth of the cells.  Once the 
cells in the control wells are nearly contiguous, each well (including the blanks) should 
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be treated with XTT dye (XTT cocktail is prepared with 500 mg of the XTT salt, 10.2 mg 
PMS and 3.3 mL DMSO).  This is a critical step as the cells should not be allowed to 
grow until starvation begins causing cell death.  Conversely, if the number of cells is too 
low, an inordinate amount of time may be required for the cells to metabolize the dye and 
adequate contrast may be difficult to obtain.  The cells are exposed to the XTT cocktail 
by first preparing a stock solution of XTT in complete medium (9.1 µL XTT mixture/2.5 
mL medium) then treating with 100 µL of the dye preparation. The plates are returned to 
the incubator until the dye has developed sufficient color for absorbance to be read on the 
plate reader (typically 2 – 4 h).  Once the plates have developed sufficient color, they 
may be read immediately or stored at 4 ºC in relative darkness until reading is convenient 
(this represents another improvement over our previously reported version of the assay). 
Stored plates should be kept in sealable plastic bags or something similar to prevent 
drying of the medium in the wells.  The ability to store the plates is yet another reason for 
using medium without phenol red as the indicator can change color due to temperature 
modification of the pH in the medium, which would interfere with accurate spectrometric 
readings later.   
For measuring absorbance, our lab uses a Tecan Safire (Tecan Systems, San Jose, 
CA) plate reader with Magellen6 software (Tecan, version 6.4).   The software provides a 
convenient methodology for reading plates with many different numbers of wells and 
subsequent saving of absorbance values to Microsoft Excel.  Absorbance measurement is 
read at 450 nm with a reference of 650 nm. 
 All data are reported as the means ± standard deviation of at least triplicate 
samples. Analysis of covariance (ANCOVA) was used to test for mean intercept 
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differences and differences in the slopes of the linear dose-response curves in cell 
viability analysis between wild-type and a series of mutant cells. A Student's t-test was 
utilized to determine the significant differences (p<0.05) between means of two groups. 
 
Test with cisplatin 
 To determine the dosage range to assure toxicity for cisplatin, dosing in different 
ranges was performed until sufficient toxicity was observed to reduce survival of the wild 
type DT40 cells to below 50% at the highest dose used.  That range was determined to be 
0 – 100 nM for cisplatin.  The cisplatin was serially diluted in DMSO and kept on ice 
until used.  The method described above was then employed to determine the survival 
rates of the DT40 cell lines.  DMSO was added to the blank wells. 
 
Test with acrolein 
 The dosage range for acrolein (Acr) was determined as above for cisplatin and 
found to be 0 – 2 µM.  Acrolein was serially diluted in PBS and kept on ice.  PBS was 
used to treat the blank wells. 
 
Statistical Methodology Development 
Model the relation between treatment dosage and survival proportion 
 
 Let x and y be treatment dose and survival proportion, respectively.  We modeled 
their relation by a linear model y = a + bx or a quadratic model y = a + bx + cx2 and 
compared the linear model and the quadratic model for each cell line by analysis of 
variance (ANOVA).  With an ANOVA p-value cutoff at 0.05, we found the quadratic 
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model fit the data significantly better than the linear model in 14 of the 31 cell lines 
treated with Acr. (Fig. A-1).  Thus we adopted the quadratic model in these 14 cell lines 
and linear model for the remaining 17 cell lines.  We could employ more complicated 
models such as higher degree polynomials or a spline model. However, as shown in the 
scatter plots in Figure A-1, linear or quadratic models already fit the data reasonably well, 
and more complicated models may lead to over-fitting.  In fact, as shown in the following 
results, our linear/quadratic method and some non-parametric approaches have given 
consistent results in terms of testing for trends and evaluating minimum effective dose 
(MED). 
 
Trend test of the dose-response relations 
 We corrected the multiple tests by the Bonferroni’s method, i.e., we used a p-
value 0.05/31 = 0.0016 as the significance cutoff.  Based on the p-values of 
linear/quadratic models (Fig. A-1), there are significant trends that the survival 
proportion decreases as the Acr dosage increases in all cell lines except for FEN1 
(p=0.03).  We also carried out a trend test based on an isotonic (monotonic) regression 
model y = f(x), where f is an unknown monotone function (Barlow et al., 1972; Hu, et al., 
2005).  Besides the monotone relation, this isotonic regression model does not assume 
any specific model forms.  We fitted the model using the “pool-adjacent-violators” 
algorithm (Barlow et al., 1972).  Following Hu et al. (Hu et al., 2005), we used a 
permutation to evaluate the p-value of the trend test.  The estimated permutation p-values 
(from 100,000 permutations) are smaller than 0.0016 for all cell lines except for FEN1 
(p=0.01).  
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Minimum effective dose 
            Given a significance level α, the MED is the lowest dose such that the mean 
response is significantly different than the mean response of the zero dose. Based on 
linear/quadratic models, the MED is simply the lowest dose where the upper bound of the 
predicted 1 - α confidence interval (CI) reaches zero.  The MED of each cell line when 
α=0.05 are indicated in Figure A-1.  
 We also employed a non-parametric method to identify MED (Williams, 1986), 
which is based on two well-known works: (Williams, 1972; Shirley, 1977).   Different 
from our model-based approach, this non-parametric method answers the question 
whether the response for an observed dose is significantly different from the response for 
the zero dose.  Therefore, based on the monotone relation assumption, we can infer 
whether the MED is between two observed doses, but not its exact value.  As shown in 
Table A-1, overall, the results of this non-parametric method are consistent with the 
results of our parametric method, despite the fact that we only have a limited sample size.  
However, our linear/quadratic parametric approach has the advantage of pinpointing the 
MED at any dose levels in addition to the observed doses.  
 
Difference across cell lines 
 Next we sought to evaluate the difference across cell lines.  We are especially 
interested in the difference between the wild type DT40 cell line and all the other cell 
lines.  Based on the linear/quadratic model fit, the difference of the predicted response 
from two cell lines follows a t-distribution. Thus we can calculate the corresponding 
prediction CI.  As shown in Figure A-2 (predicted difference and the corresponding 95% 
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CI), nine cell lines, ASCIZ, ATM, BRCA1, FEN1, LIGIV, MSH2, POLΚ, RAD54, and 
WRN may have significantly different survival proportions compared with that of cell 
line DT40. 
  
Results and Discussion 
Reproducibility and sensitivity in the DT40 cell DNA damage response analysis using the 
XTT method 
 
 To address reproducibility of the response of DT40 parental cells to mutagens, we 
exposed DT40 cells to MMS, a strong DNA alkylating agent whose damage is repaired 
by BER, at different concentrations in three independent experiments.  Figure 2-3A 
indicates the level of reproducibility achieved from those experiments. We tested for 
statistical difference between the three results for 50% lethal concentration (LC50) values, 
slope and y-axis interception. These analyses provide no significant difference, 
suggesting a reasonable reproducibility of our assay for measuring the response in DT40 
cells to MMS in terms of cell viability. We also compared DT40 cells and POLB (a BER 
polymerase) mutants exposed to MMS for cell viability (Fig. 2-3B). The statistically 
significant difference in dose-response relationship between two cell lines was detectable 
as low as 37.5 µM of MMS. This sensitivity appears to be similar to the results obtained 
by clonogenic analysis (Yoshimura et al., 2006). 
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Comparison of cisplatin exposure results between the DT40 XTT dye and clonogenic 
methods 
Cisplatin  
 To assess for any difference of results between the DT40 XTT dye and the 
clonogenic methods, cisplatin, a DNA cross-linking agent has been chosen.  For the 
purpose of this comparison, we have chosen to report on three DT40 mutant cells lines 
that are known to be involved in the repair of DNA interstrand crosslinks (ICL): the DNA 
helicase, BLM, and the enzymes, XRCC2 and FANCD2.  Cells lacking these proteins are 
known to be hypersensitive to DNA cross-linking agents.  In addition, we have chosen 
the flap endonuclease, FEN1, which should show little, if any, additional sensitivity to 
cisplatin beyond the wt.  As depicted in Figure 2-4A the results for the BLM, XRCC2 and 
FANCD2 mutants indicate quite strong sensitivity for these mutants compared with the 
wt, while the FEN1 knockout showed little sensitivity.  This result for XRCC2 shows 
very close agreement for relative sensitivity with the wt to that of Takata, et al., although 
our result indicated sensitivity for both the wt and the mutant at much lower 
concentrations due to continuous treatment (Takata et al., 1998).  Takata, et al., using the 
clonogenic assay, report that XRCC2 mutants were approximately 8-fold more sensitive 
to cisplatin than the normal cells while we showed an approximate 5-fold increase (an 
LC50  of 22% compared with the wt) in sensitivity (Fig. 2-4B).  This result for XRCC2 
exposure also shows excellent agreement with Nojima, et al., who reported an 
approximate 25% D1 survival compared with the wt, using the colony formation assay 
(Nojima et al., 2005).  The result for the BLM mutant using the XTT method produced an 
LC50 of 22% compared with the wt, whereas Nojima, et al., were somewhat higher with a 
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D1 survival at ~ 45%.  For the FANCD2 mutant exposed to cisplatin, we found a 
profound sensitivity where the LC50 survival was only 9% that of the normal cells.  This 
result agrees well with that obtained by Matsushita, et al., which were ~ 5% using the 
clonogenic method (Matsushita et al., 2005).  As expected, the XTT method with FEN1 
mutants indicated an LC50 of 87% compared with the wt, while Nojima, et al., was ~ 90% 
in their laboratories clonogenic assay (Nojima et al., 2005). 
 
Further validation of the DT40/XTT assay with the genotoxic agent, acrolein 
 
Acrolein  
Acrolein (2-propenal), an α,β−unsaturated aldehyde, is a highly reactive 
bifunctional electrophile, and can react by Michael-addition with DNA bases at various 
positions with the exocyclic nitrogen (N2) of deoxyguanosine (dG) providing the most 
common target (Minko et al., 2008) (Fig. 2-5).  Human exposure to Acr may be divided 
into three main source groups including dietary, endogenous and environmental sources.  
Endogenous sources include products of lipid peroxidation and products of the 
metabolism of polyamines (Stevens and Maier, 2008).  Acr is also ubiquitous in the 
environment with sources such as the incomplete combustion of petroleum, coal, wood 
and plastic, the frying of foods in oils, and the smoking of tobacco products (reviewed by 
Esterbauer et al., 1991).  Exogenous Acr is absorbed by human cells with reasonable 
efficiency and can react with cellular molecules directly without metabolic activation.  
Acr has been identified in at least 32 hazardous waste sites that have been proposed for 
inclusion on the EPA National Priorities List (Foroon et al., 2008) and has been listed 
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thirty-seventh on the 2007 CERCLA Priority List of Hazardous Substances.  Of all 
sources, the smoking of tobacco products provides at least as much human exposure as 
all other sources combined (Stevens and Maier, 2008).  Indeed, Acr has been found in 
cigarette smoke at levels up to 1000-fold of those for benzo[a]pyrene, a known cancer 
inducer (Feng et al., 2006).  
Acr is cytotoxic and some reports show it to be mutagenic, although the 
mutagenicity of its major adduct with DNA is controversial (Minko et al., 2008; Kim et 
al., 2007; Stevens and Maier, 2008).  The major product of reaction between Acr and N2-
dG is γ-hydroxypropano-deoxyguanosine (γ-HOPdG) with α-hydroxypropano-
deoxyguanosine (α-HOPdG) being formed in much lesser amounts (Chung et al., 1984) 
(Fig. 2-5). These lesions have been measured in various human tissues to be in the range 
from 1-200/108 guanine (reviewed in Nair, 2007). The ability of α-HOPdG to be 
mutagenic is fairly well established (Wang et al., 2009), but mutagenicity of the dominant 
adduct, γ-HOPdG, remains to be clarified.   
Although the γ-HOPdG adduct may exist in equilibrium between the ring-open 
and ring-closed forms, it has been shown to prefer the ring-open form at neutral pH with 
the N2-(3-oxopropyl) group protruding into the minor groove in double-strand DNA 
(dsDNA) (de los Santos et al., 2001).  As with formaldehyde, Acr induced mutagenesis 
has been proposed to be the result of DPC caused by reaction of the propano-aldehyde, 
found in the ring-open γ-HOPdG adduct (Fig. 2-5, Rxn A), with nucleophiles such as the 
amine groups of amino acid side chains. Some reports have suggested that these γ-
HOPdG-mediated DPC are repaired by nucleotide excision repair (NER) (Yang et al., 
2001; Minko et al., 2005; Baker et al., 2007) and probably not base excision repair 
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although other DNA repair mechanisms have not been well studied and may be found to 
be involved.  Also, there have been numerous reports involving TLS of Acr-DNA 
adducts and most but not all have indicated that such bypass is mostly error-free in 
mammalian cells (Kanuri et al., 2002; Minko et al., 2003; Yang et al., 2001; Yang et al., 
2003; Washington et al., 2004). 
 
Acrolein Results 
 Our purpose in this study has been to investigate the DNA repair mechanisms 
used by cells to alleviate damage caused by Acr along with the additional intention being 
to further verify our DT40 assay against a well studied chemical.   To this end we have 
made use of the DT40 cell line including 28 isogenic mutants deficient in DNA repair 
pathways as well as some cell cycle checkpoint and DNA damage sensor mutants 
described in Chapter 1.  In a another study using the same system we found that cells 
deficient in FANCD2, the breast cancer 1 (BRCA1), breast cancer 2 (BRCA2) and others 
of the HR repair proteins for which we have mutants, are hypersensitive to formaldehyde 
at a concentration normally found in human plasma (Ridpath et al., 2007).  From these 
results we postulated that the FANC/BRCA pathway is required for the repair of DPC 
mediated by formaldehyde.  For this study we hypothesized, based on our formaldehyde 
results, that acrolein adducts, which putatively also form similar DPC to formaldehyde 
would cause hypersensitivity in the HR mutants.  Our data indicates that this may not be 
the case – especially with mutants of the FANC/BRCA pathway.  The FANCD2, BRCA1 
and BRCA2 mutants were not particularly sensitive to Acr when compared with the 
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DT40 isogenic parent.  This outcome suggests that Acr may not induce DPC in vertebrate 
cells. 
 In the last several years a number of in vitro studies have been performed that 
suggest that DNA interstrand cross-links could be mediated by the γ-HOPdG adduct 
(Stone et al., 2008; Kozekov et al., 2003; Cho et al., 2005).  DNA interstrand cross-links 
have been shown to require HR and the FANC/BRCA pathway for their repair (Panasci 
et al., 2002; Wang and D’Andrea, 2004; Pichierri and Roselli, 2004).  Our results with 
FANCD2 along with our results here with BRCA1 and BRCA2 have indicated no 
particular sensitivity to Acr (Fig. 2-6) in these mutants (although some other HR mutants 
were mildly sensitive).  Thus, these results suggest that, along with DPC, DNA 
interstrand cross-links are not induced by Acr in vertebrate cells.  
 Our findings do agree with those that suggest that TLS is responsible for dealing 
with DNA damage induced by Acr in vertebrate cells.  In particular, the DNA TLS 
polymerase κ (POLΚ) and polymerase η (POLΗ) appear to be more sensitive than the wt, 
although, of the two, only the POLΚ results were found to be significantly different from 
the wt under the scrutiny of our statistical method.  These results are in agreement with 
others that have indicated that TLS (Fig. 2-6) is involved (Minko et al., 2009; Minko et 
al., 2008; Minko et al., 2003; Yang et al., 2003). 
 Lastly, and perhaps most noteworthy, we must consider the Acr concentrations 
responsible for our observations when compared with previous studies.  Whereas the wt 
DT40 cells produced an LC50 of 2.71 µmole/L upon exposure to Acr, LC50 POLΚ and 
POLΗ were 1.07 µmole/L (39.5% wt) and 1.00 µmole/L (36.9% wt).  To our knowledge, 
these values represent the lowest ones found in vertebrate cell studies to date and are near 
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or below the normal levels of Acr found in human plasma (0.50 – 30 µmole/L), or well 
below the levels found in certain pathophysiological occurrences (Sakata et al., 2003; 
Garrett et al., 2008; Tomitori et al., 2005). 
 
Advantages of the XTT dye method over the clonogenic method 
 
As can be observed in Table 2-2, there is a dramatic reduction in materials, 
manipulation and cost required for the XTT dye method.  Also, and just as importantly, 
much more data can be acquired per unit time.  This should be especially attractive to 
government agencies that wish to quickly establish correct and effective biomarkers so 
that more meaningful regulations may be determined on a timely basis. 
As far as we are aware, only two studies have performed multi-well based DT40 
cell DNA damage response analysis using more than 12 different cell lines.  One of these 
reports is our previous study regarding formaldehyde (Ridpath et al., 2007).  The other 
recently reported using DT40 mutant cells with a 12/24-well format to analyze DNA 
damage responses to UV/ionizing radiation and NaAsO2  (Ji et al., 2009).  That particular 
investigation also compared their 12/24-well plate assay and the clonogenic assay with 
regard to sensitivity and produced very comparable results between the two methods.  
These data combined with results from the present study indicate that a multi-well plate-
based DT40 cell assay is reasonably sensitive for the detection of genotoxicity induced 
by diverse agents such as formaldehyde, cisplatin, MMS, UV/ionizing radiation and 
NaAsO2.        
Additionally, the XTT dye method may lend itself readily to automation, whereas 
it is doubtful the same could be said for the clonogenic method.  The advantage of 
 37
automation becomes obvious if one wishes to use the method as a screen to aid in the 
determination of the MOA of numerous environmental chemicals.  In fact, the ability of 
the DT40 system to provide very specific information about the DNA repair pathway 
used to alleviate damage induced by a chemical agent could become one of the most 
valuable tools in the chest of those given the responsibility to ascertain the 
genotoxicity/mutagenicity of the agent.  Also, and perhaps even more importantly, 
currently available DT40 mutant cell line has originated from a single parent and is 
therefore isogenic.  This reduces greatly the uncertainty found with other systems where 
mutant cell lines have been created from different sources – which further increases the 
value of DT40 in the determination of the MOA.  
 Taking into consideration the forgoing we conclude that, while the DT40 
clonogenic assay is very accurate, it is somewhat cumbersome, costly and time 
consuming for use as a screen for toxicological purposes where a higher throughput may 
be desired.  We have shown that our DT40/XTT method can provide comparative 
accuracy and sensitivity with the clonogenic method while doing so with much less 
tedium, cost and especially time to produce results. 
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Chapter 2 Figures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure -1. XTT metabolization to formazan salt 
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Figure 2-2.  Protocol overview of XTT-based DT40 
cell DNA damage response analysis using 24-well 
plate format.
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Figure 2-3. Cell survival results for DT40 cells and POLB mutants continuously exposed to MMS. 
(A) Results of three independent survival experiments in DT40 cells exposed to MMS. Survival 
data were log-transformed giving approximate normality. Analysis of covariance (ANCOVA) was 
used to test for mean intercept differences and differences in the slopes of the linear dose-
response curves in cell viability analysis between experiments. No significant difference (p<0.05) 
was detected between experiments. (B) Survival percentage for DT40 and POLB mutant cells 
exposed to MMS compared with concurrent control. A Student's t-test was utilized to determine 
the significant differences between means of two groups (DT40 (II) vs. POLB exposed to MMS at 
same concentration, **P < 0.01). (C) Survival data from DT40 (II) and POLB cells exposed to 
MMS were log-transformed giving approximate normality. Each LC50 value was then calculated 
for each cell line. ANCOVA showed a significant difference for mean intercepts of the linear dose-
response curves between wild-type and POLB cells (**P < 0.01). Bars: 95% confidence intervals 
for LC50 value for each cell line.  
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Figure 2-4. Cell survival results for DT40 cells and their isogenic mutants continuously exposed to 
cisplatin. (A) Survival percentage for each cell line exposed to cisplatin compared with concurrent 
control. (B)  Survival data were log-transformed giving approximate normality. Black columns 
indicate significant differences analyzed by ANCOVA (p<0.01) between parental DT40 cells and 
mutants (BLM, XRCC2 and FANCD2 cells). In contrast, FEN1-deficient cells showed no 
significant difference by ANCOVA (p>0.05). Bars: 95% confidence intervals for LC50 value for 
each cell line. 
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Figure 2-6. Cell survival results for DT40 cells and their isogenic mutants continuously exposed to 
acrolein. (A) Survival percentage for HR cell lines exposed to acrolein compared with concurrent 
control. (B)  Survival percentage for TLS cell lines exposed to acrolein compared with concurrent 
control. Survival data were log-transformed giving approximate normality.  
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Chapter 2 Tables. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         Table 2-2. Comparison of clonogenic method to XTT dye method 
 
 Clonogenic method (Simpson and Sale 
2006) 
XTT dye method  
Medium Methylcellulose medium requiring 
overnight mixing, pH adjustment, etc.  
Complete medium requiring about 
5 min preparation time 
Plates One 6-well plate/cell line/dose totaling 
20 plates for 4 cell lines and 5 doses 
One 24-well plate/cell line with up 
to 6x3 doses on a single plate 
Plating of 
samples 
Separate pipetting of medium (with 
more stirring) and cell samples 
A single addition of cell suspension 
to well 
Incubation period  10 days to 2 weeks 3-4 days 
Test method Requires centrifugation, washing and 
resuspension of cells 
No centrifugation/resuspension of 
cells 
 
Measurement Manual colony counting – one cell 
line/dose at a time.  Plates should be 
counted promptly when ready 
Absorbance reading on plate reader 
– one complete cell line with all 
doses at a time.  
Plates can be stored at 4 oC until 
convenient to read. 
Estimated daily 
data 
accumulation 
8 cell lines with 5 doses/cell line  
(40 plates) 
80-100 cell lines with 6 doses/cell 
lines plus control 
 
 
 
Numbers represent dosing solutions: from highest concentration ( 1) to 
lowest (6); C: control (cells plus vehicle only); Bl: blank (complete 
medium without cells plus vehicle).
BlBlC444
CCC333
666222
555111
Table 2-1. Format for Treatment of 24-well Plate
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Chapter 3.  Use of the DT40/XTT Assay in the Determination of the DNA Repair 
Pathway Responsible for the Tolerance of Formaldehyde Genotoxicity 
 
Abstract  
 Formaldehyde is an aliphatic monoaldehyde and is a highly reactive 
environmental human carcinogen. While humans are continuously exposed to exogenous 
formaldehyde, this reactive aldehyde is a naturally occurring biological compound that is 
present in human plasma at concentrations ranging from 13 to 97 µM. It has been well 
documented that DPCs likely play an important role with regard to the genotoxicity and 
carcinogenicity of formaldehyde.  However, little is known about which DNA damage 
response pathways are essential for cells to counteract formaldehyde.  In the present 
study, we first assessed the DNA damage response to plasma levels of formaldehyde 
using chicken DT40 cells with targeted mutations in various DNA repair genes.  Here we 
show that the hypersensitivity to formaldehyde is detected in DT40 mutants deficient in 
the BRCA/FANC pathway, homologous recombination or translesion DNA synthesis.  In 
addition, FANCD2-deficient DT40 cells are hypersensitive to acetaldehyde, but not to 
acrolein, crotonaldehyde, glyoxal, and methylglyoxal. Human cells deficient in FANCC 
and FANCG are also hypersensitive to plasma levels of formaldehyde. These results 
indicate that the BRCA/FANC pathway is essential to counteract DPCs caused by 
aliphatic monoaldehydes.  Based on the results obtained in this Specific Aim, we are 
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currently proposing that endogenous formaldehyde might have an impact on highly 
proliferating cells, such as bone marrow cells, as well as an etiology of cancer in FA 
patients. 
 
Introduction  
 Formaldehyde is an aliphatic monoaldehyde and is a highly reactive 
environmental pollutant found in automobile emissions and tobacco smoke.  Several 
studies have demonstrated genotoxicity and carcinogenicity due to formaldehyde 
(Monticello et al., 1996; Emri et al., 2004).Recently, formaldehyde has been re-evaluated 
by the IARC as a known environmental human carcinogen (Group 1) due to a positive 
association between the extent of formaldehyde exposure of workers and their death from 
nasopharyngeal cancer (Cogliano et al., 2005).  While humans are continuously exposed 
to exogenous formaldehyde, this chemical is also a naturally occurring biological 
compound that is present in all tissues, cells and bodily fluids.  Formaldehyde and its 
oxidation product, formic acid, function as key intermediates in the “one-carbon pool” 
(Neuberger 1981) utilized for the biosynthesis of purines, thymidine and some amino 
acids.  It has been found that the concentration of endogenous formaldehyde in human 
plasma ranges from 13 to 97 µM (Szarvas et al., 1986; Heck and Casanova, 2004; Luo et 
al., 2001) with Heck, et al., reporting an average of 82 µM (calculated using 1.06 for the 
density of human blood).  Formaldehyde is usually rapidly metabolized by reduction, 
oxidation and glutathione (GSH)-dependent pathways (Koivusalo et al., 1989).  However, 
saturation in formaldehyde metabolism may lead to DNA damage.  It has been well 
documented that cells exposed to formaldehyde exhibit, as a major form of DNA damage, 
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DPCs (Quievryn and Zhitkovich, 2000; Casanova et al., 1991) which are clastogenic due 
to their ability to arrest DNA replication (Hubal et al., 1997) (Fig. 3-1).  Failure to 
remove the lesion or fully repair it before cell division can frequently cause cell death or 
chromosome aberrations.  Cellular DNA is found in tight association with proteins 
involved in both structural organization of the genome and others that control cellular  
processes. In fact, DNA-histone crosslinks have been shown to have a strong correlation 
with formaldehyde-induced tumor incidence in animals.  As a result, the level of 
formaldehyde-induced DPCs is considered to be a good molecular dosimeter for 
formaldehyde cancer risk assessment (USEPA, 1991; Casanova et al., 1991; Hubal et al., 
1997).  Although understanding the importance of DPCs with regard to the genotoxicity 
of formaldehyde is paramount, little is known about which DNA damage response 
pathways are essential for cells to counteract formaldehyde. 
 Fanconi anemia, an inherited disorder, is characterized by developmental 
abnormalities and is associated with progressive bone marrow failure and predisposition 
to malignant leukemia and solid tumors (D`Andrea and Grompe, 2003; Fanconi, 1967).  
FA is a rare disease with heterozygosity existing at a frequency of approximately 0.3% to 
1% of the population (Joenje and Patel, 2001). It has been documented that cells from FA 
patients are hypersensitivity to DNA-DNA crosslinking agents (D`Andrea and Grompe, 
2003), and there is increased chromosomal breakage induced by these agents.  At least 13 
FANC complementation groups (A,B,C,D1,D2,E,F,G,I,J,L,M,N) have been identified 
(Kennedy RD and D`Andrea AD, 2006).  These proteins interact in a common pathway 
that activates FANCD2 via monoubiquitination (Kennedy and D`Andrea, 2006).  Upon 
recognition of a stalled replication fork, for instance, by the nuclear E3 monoubiquitin 
 46
ligase core complex, activated FANCD2 is targeted to BRCA1 nuclear foci where it 
regulates DNA repair by possibly HR and TLS (Kennedy and D`Andrea, 2006).  DT40 
cells and their isogenic mutants have predominantly been utilized to investigate the 
function of various gene products (Yamazoe et al., 2004).  In this Specific Aim, we 
assessed the DNA damage response to formaldehyde by the reverse genetic approach 
using the DT40 cell model system and isogenic human cancer cells deficient in the 
FANC pathway. 
 
Materials and methods 
Materials.   
 Fetal bovine serum, XTT, PMS, acetaldehyde, acrolein, glyoxal, and 
methylglyoxal were obtained from Sigma. Formaldehyde and crotonaldehyde were 
purchased from Fisher Scientific and Across Organics, respectively.  The total 
glutathione (GSH) quantification kit was from Dojindo Molecular Technologies, Inc.  
RPMI-1640 culture medium, chicken serum and penicillin/streptomycin were obtained 
from Invitrogen. 
 
Cell lines and cell culture.   
 All DT40 mutants were derived from isogenic DT40 parent cell lines (Table 1).  
The DT40 cells and their mutants were cultured as previously reported (Tano et al., 2007).  
Parental colorectal cancer cell lines (RKO) cells and isogenic clones harboring an 
engineered disruption of FANCC or FANCG (Gallmeier et al., 2006) were cultured in a 
humidified 5% CO2 atmosphere at 37°C. The medium consisted of RPMI-1640 cell 
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culture medium containing 10% fetal bovine serum (heat inactivated), and 100 mg/ml 
penicillin and 100 mg/ml streptomycin. 
 
Cell survival assay. 
 For DT40 cells and their mutants, suspended cells (approximately 600 cells/250 
µL/well) were seeded into 24-well plates, exposed to formaldehyde (and other aldehydes) 
and allowed to divide for approximately ten cycles.  The formaldehyde used was 37% 
aqueous and was serially diluted in sterile 1x PBS (Gibco) to obtain the appropriate 
concentrations in the plates.  All formaldeyde dilutions were made fresh and kept on ice.  
(Initially, a colony formation assay was attempted, but discontinued as it appeared 
formaldehyde reacted adversely with the methylcellulose semisolid medium). After 
cultivation, cell viability was determined by the XTT assay (Scudiero et al., 1988). For 
RKO cells and their isogenic cells deficient in FANCC or FANCG, the adhesive cells 
(approximately 600 cells/250 µL/well) were seeded into 24-well plates and cultivated for 
two days before treatment. After changing to fresh medium, the cells were exposed to 
formaldehyde and allowed to divide for seven days. The medium was replenished at four 
days after treatment. The survival rates were determined as described above. 
 
Determination of intracellular total GSH. 
 Total GSH levels were measured according to the manufacturer's directions using 
a commercially available kit. Briefly, 5,5'-dithiobis-(2-nitrobenzoic acid) and GSH react 
to generate 2-nitro-5-thiobenzoic acid.  The concentration of 2-nitro-5-thiobenzoic acid in 
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the sample solution was determined by measuring absorbance at 412 nm and comparison 
to a standard curve. 
 
Statistical analysis.  
 Survival data were log-transformed giving approximate normality. Analysis of 
covariance (ANCOVA) was used to test for mean intercept differences and differences in 
the slopes of the linear dose-response curves between wild-type and a series of mutant 
cells.  
 
Results and discussion  
HR repair and NHEJ repair of DNA damage induced by formaldehyde.  
 We assessed the contribution of each DNA damage response pathway to 
formaldehyde-induced DNA damage. Toward this end, we utilized a panel of isogenic 
DT40 cell mutants, each of which was defective in a particular DNA repair or cell-cycle 
checkpoint response pathway. Here we show that formaldehyde causes a reduction in 
survival of DT40-derived mutants that are deficient in HR repair. The HR repair pathway 
mutants showed sensitivity to formaldehyde in the following order: FANCD2 >> 
BRCA2 > BRCA1, XRCC2, RAD51C, RAD51D, XRCC3, RAD54 > RAD52 > parent 
DT40 cells (Figure 3-2). In contrast, cell survival rates were largely equivalent between 
NHEJ-deficient cells and parent DT40 cells (Fig. 3-3). One of the metabolic pathways 
used by cells to detoxify formaldehyde is GSH-dependent. Therefore, we tested whether 
there is an association between intracellular GSH levels and hypersensitivity of HR-
deficient cells to formaldehyde. However, we found no correlation between GSH 
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concentrations and formaldehyde-induced cell toxicity in series of isogenic DT40 cells. 
These results revealed a requirement for the HR pathway, but not the NHEJ pathway in 
processing DNA damage induced by formaldehyde, strongly suggesting that the HR 
pathway is involved in repair of DPCs.  
 
Role of excision repair pathways in the repair of DNA damage induced by formaldehyde.  
 Results of biochemical experiments have indicated that nucleotide excision repair 
(NER) is involved in the elimination of DPCs (Minko et al., 2002; Reardon and Sancar, 
2006). However, the relative contribution of the various excision repair pathways to the 
removal of DPCs has not been fully characterized. Therefore, we tested each excision 
repair pathway (NER and BER) as to its effectiveness in removing DPCs caused by 
formaldehyde. Our results show hypersensitivity in the following order: PARP1 
(BER/single and double strand break repairs) > XPA (NER) > POLβ (BER) > FEN1 
(BER) (Fig. 3-4). The DT40 mutants for POLB and FEN1 showed slight to marginal 
hypersensitivity, indicating that BER is not heavily involved in DPC repair. PARP1 is 
used in many pathways such as BER, single strand break repair, stabilization of 
replication forks and possibly double strand break repair (Schreiber et al., 2006; 
Hochegger et al., 2006). Thus, since POLB and FEN1 sensitivities indicate that BER is 
probably not highly implicated in formaldehyde-induced DPC repair, the higher 
sensitivity of the PARP1 mutant may be due to its role in DNA replication and double 
strand break repair in cells exposed to formaldehyde. In addition to PARP1, the 
xeroderma pigmentosum complementation group A protein (XPA), likely plays a 
moderate role for counteracting DNA damage induced by formaldehyde. These results 
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obtained from XPA-deficient DT40 cells agree with a previous study, which 
demonstrated that human fibroblasts deficient in NER (XPA and XPF) were slightly 
hypersensitive to formaldehyde in cell survival (Quievryn and Zhitkovich, 2000). 
 
Role of translesion DNA synthesis and cell-cycle checkpoint pathways in the repair of 
DNA damage induced by formaldehyde.  
 In the DT40 cell model system, REV1, REV3, and RAD18-deficient cells have 
been reported to be hypersensitive to various ICL-inducing agents including cisplatin and 
mitomycin C (Nojima et al., 2005; Shen et al., 2006). To determine the role of TLS in the 
repair of DNA damage induced by formaldehyde we exposed DT40 and DT40 cells 
deficient in REV1, REV3, and RAD18 along with POLQ to formaldehyde. For the REV1, 
REV3, and RAD18 mutants our results show good agreement with the ICL study while 
POLQ mutants were only marginally sensitive to formaldehyde (Fig. 3-4). Proliferating 
cell nuclear antigen (PCNA) has been reported to be partly ubiquitinated in a RAD18-
dependent manner and this monoubiquitination of PCNA is necessary for carrying out 
TLS by polymerase η in yeasts (Haracska et al., 2004; Hoege et al., 2002). In addition, it 
has been proposed that ATR/CHK1 signaling is required for RAD18-mediated PCNA 
monoubiquitination against DNA damage induced by benzo[a]pyrene dihydrodiol 
epoxide (Bi et al., 2006). To further characterize the DNA damage response to 
formaldehyde, we exposed formaldehyde to cells deficient in the S-phase cell-cycle 
components ATM or CHK1. Formaldehyde sensitivity in these cells was similar to 
parental cells (Fig. 3-4). These results suggest that neither the ataxia telangiectasia 
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mutated (ATM) nor the CHK1 pathways participate in the DNA damage response to 
formaldehyde-induced DNA damage. 
  
Role of FANCD2 in the repair of DNA damage induced by endogenously existing 
aldehydes other than formaldehyde.  
 Using DT40 cells deficient in FANCD2, the most sensitive cell line to 
formaldehyde, we addressed whether other major endogenously existing aldehydes cause 
similar hypersensitivity to FANCD2 cells. Among the endogenously existing aldehydes 
potentially capable of inducing DPCs (Kuykendall and Bogdanffy, 1992), acetaldehyde 
caused hypersensitivity in FANCD2 cells at millimolar levels (Fig. 3-5A). Methylglyoxal 
(Fig. 3-5B), glyoxal (data not shown), acrolein and crotonaldehyde (Fig. 3-5C,D) showed 
no hypersensitivity in FANCD2 cells (Fig. 3-5B to 5D). These results suggest that the 
FANC pathway may be essential to counteract DPCs induced by aliphatic short 
monoaldehydes, but not DPCs caused by either aliphatic dicarbonyl compounds or α,β-
unsaturated aldehydes. Another possibility is that either α,β -unsaturated aldehydes or 
aliphatic dicarbonyl compounds may more efficiently introduce other types of deleterious 
DNA lesions, such as exocyclic base adducts or oxidative base lesions.  
 
Endogenous DPC-inducing agents and Fanconi anemia.   
 Fanconi anemia, a rare disease with heterozygosity existing at a frequency of 
approximately 0.4% of the population (Schroeder et al., 1964), is an inherited disorder 
associated with progressive bone marrow failure and predisposition to malignant 
leukemia and solid tumors (Kennedy and D`Andrea, 2006). It has been documented that 
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cells from FA patients are hypersensitive to DNA interstrand crosslinking agents 
(Kennedy and D`Andrea, 2006), with an associated increase in chromosomal breakage. 
We know, however, of no report that has described a condition whereby endogenous 
reactive agents such as formaldehyde have induced DPCs with the further induction of 
toxicity in cells deficient in the FANC pathway. It has been reported that endogenous 
formaldehyde in human plasma is detectable at concentrations ranging from 13 to 97 µM 
(Szarvas et al., 1986; Heck and Casanova, 2004). The two most sensitive DT40 mutants 
are FANCD1 (BRCA2)- and FANCD2-deficient cells, which showed hypersensitivity to 
formaldehyde at concentrations between 10 and 15 µM. This observation raises a 
question about the relevance of data derived from the DT40 model system to the human 
cellular response to formaldehyde. Therefore, we exposed RKO cells and their isogenic 
cells disrupted in FANCC or FANCG. The human cells deficient in either FANCC or 
FANCG were hypersensitive to formaldehyde at concentrations 20 mM or higher 
(FANCC) or 38 mM or higher (FANCG) (Fig. 3-6). These results indicate that the 
FANC/BRCA pathway plays a critical function in not only DT40 cells, but in human 
cells. Therefore, we currently hypothesize that endogenous formaldehyde induces DPCs 
and plays a critical role in the initiation of progressive bone marrow failure or 
predisposition to malignant tumors in FA patients. 
 
Possible DNA repair pathways for DPCs induced by formaldehyde.  
 It is widely accepted that formaldehyde predominantly introduces DPCs in cells. 
The DPC formation is believed to be related to formaldehyde-induced cancer in animals 
and humans; however, little information is available in terms of the DNA damage 
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response to formaldehyde. Interestingly, we recognized that the DNA damage responses 
to formaldehyde in the DT40 cell model system were similar to those of cisplatin 
(Nojima et al., 2005). For example, survival of isogenic DT40 mutants to cisplatin is in 
the following order: REV3 > FANCC > RAD18 > XRCC2 > XRCC3 > PARP1 > 
RAD54 > BRCA1 > XPA = ATM > BRCA2 = MSH3 > parental DT40 cells. Since both 
DNA-DNA crosslinks and DPCs have the potential to cause stalled DNA replication 
forks and may introduce double strand breaks, hypersensitivity of HR-deficient cells to 
formaldehyde is likely due to DPCs. Furthermore, cisplatin induces DPCs in addition to 
inter- or intra-strand crosslinks. The similarity of the DNA damage response in DT40 
mutants to cisplatin and formaldehyde also raised the possibility that DPCs caused by 
cisplatin may have a role in the hypersensitivity of DT40 cells deficient in the 
FANC/BRCA and HR pathways. We also found hypersensitivity of PARP1-deficient 
DT40 cells to formaldehyde. Interestingly, PARP-1 also inhibits HR from interference by 
KU and LIGASE IV in DT40 cells (Hochegger et al., 2006). This report, combined with 
our results, suggests that without precise regulation of HR in the absence of PARP1, the 
HR repair pathway for the repair of double strand breaks induced by DPCs may not 
efficiently restore the integrity of genomic DNA. Although XPA mutants are more 
resistant to formaldehyde compared with HR-deficient cells (a characteristic shared with 
cisplatin) (Nojima et al., 2005), XPA-deficient cells were moderately hypersensitive to 
formaldehyde, suggesting a reasonable role for NER in the elimination of DNA damage 
caused by formaldehyde. Figure 3-7 shows a possible DNA repair pathway to counteract 
DPCs induced by formaldehyde. In the error-free DPC excision process, formaldehyde-
induced DPCs could be first degraded to DNA-amino acid crosslinks (DAC) by a cellular 
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proteasome. The NER pathway may recognize and eliminate the DACs followed by 
DNA repair synthesis (Minko et al., 2002;  Reardon and Sancar, 2006;  Quievryn and 
Zhitkovich, 2000). In contrast, error-prone DPC excision processes could exist to tolerate 
formaldehyde-induced damage. After degradation of DPCs to DACs but before initiation 
of excision repair, DNA replication may start and TLS DNA polymerases may by-pass 
and extend DNA synthesis past the DACs. After DNA replication, the NER pathway may 
recognize and eliminate the DACs followed by DNA repair synthesis. Since HR-deficient 
cells are hypersensitive to formaldehyde, the requirement for HR repair for uncoupling of 
initiation of DNA replication and excision repair processes can be hypothesized. The 
NER pathway recognizes and eliminates DACs. Before the completion of excision repair, 
DNA replication could begin and lead to the formation of DNA double strand breaks with 
subsequent repair by a HR-dependent pathway. Another possibility is that DPCs formed 
during DNA replication cause stalled DNA replication forks, followed by the formation 
of DSBs. The HR-dependent pathway could then repair these DSBs.  
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Figure 3-1. Formation of DNA-protein cross-link with 
formaldehyde
R1 = amino acid side chain group; R2 = base amine 
group. Adapted from Barker et al., (2005) Mut Res 589; 111-135.
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Figure 3-2. Relative LC50 values and linear regression analysis 
cell survival results in DT40 cells and their mutants exposed to
formaldehyde. (A) Each LC50 value was calculated from results of
cell survival data shown in Figures 2 to 4. Relative LC50 values
were normalized according to the LC50 value of parental wild-type 
cells. (B) Survival rates were log transformed for ANCOVA analysis 
to compare slopes or interceptions between two lines generated by 
linear regression lines derived from DT40 wild-type cells and 
mutants. The value of the slopes was calculated from survival data 
and was plotted for each mutant. All mutants except ku70 (one of 
the white columns, N.S.: no significance) showed statistically 
significant difference in slopes or interception (p<0.05). (Ridpath, et 
al., (2007) Cancer Res,67; 11117-11122.)
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Figure 3-3. Sensitivity of wild-type (wt) and HR- and NHEJ- deficient cells after 
exposure to formaldehyde.  The concentrations of formaldehyde are displayed on the x-
axis on a linear scale, while the survival rates are displayed on the y-axis in a 
logarithmic scale. Error bars show the standard deviations (SD) of the mean for three or 
four wells.  Reproducibility was confirmed at least three times. (Ridpath, et al., (2007) 
Cancer Res,67; 11117-11122.)
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Figure 3-4. Sensitivity of wild-type (wt) and BERNER, TLS and Cell Cycle 
Checkpoint-deficient cells after exposure to formaldehyde.  The concentra-tions of 
formaldehyde are displayed on the x-axis in a linear scale, while the survival rates 
are displayed on the y-axis in a logarithmic scale. Error bars show the SD of the 
mean for three or four wells.  Reproduc-ibility was confirmed at least three times. 
(Ridpath, et al., (2007) Cancer Res,67; 11117-11122.)
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Figure 3-5.  Sensitivity of DT40 cells and DT40-derived FANCD2-deficient cells to 
aldehydic agents. (A) Survival of DT40 cells and FANCD2-deficient cells after 
exposure to acetaldehyde, (B) methylglyoxal, (C) acrolein and (D) 
crotonaldehyde. The concentration of each aldehyde is displayed on the x-axis in 
a linear scale, whereas the survival rates are displayed on the y-axis in a 
logarithmic scale. Point, mean for three or four wells; bars, SD. Reproducibility 
was confirmed at least three times. (Ridpath et al., (2007) Cancer Res, 67; 
11117-11122) 
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Figure 3-6. Sensitivity of parental RKO cells and their isogenic FANCC-/-/- and 
FANCG-/- cells after exposure to formaldehyde. The concentrations of 
formaldehyde are displayed on the x-axis in a linear scale, while the survival 
rates are displayed on the y-axis in a logarithmic scale. Error bars show the SD 
of the mean for three or four wells. Reproducibility was confirmed at least three 
times. (Ridpath, et al., (2007) Cancer Res,67; 11117-11122.) 
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Figure III-7. Hypothesized pathway for the repair of DPC. DSB, double-strand 
break. (Ridpath, et al., (2007) Cancer Res,67; 11117-11122.) 
 
 
 
 
 
 
 
 
 
Figure 3-7. Hypothesized pathway for the repair of DPC. DSB, 
double-strand break. (Ridpath, et al., (2007) Cancer Res,67; 
11117-11122.)
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Chapter 4.  Use of the DT40 Cell System for the Determination of the DNA Repair 
Pathway Responsible for the Tolerance of Hexavalent Chromium Genotoxicity 
 
Abstract 
 Chromium has long been widely used industrially by-products of chromium usage 
pose an environmental health risk and is a known human carcinogen.  Of the three 
oxidation states of chromium found in the environment Cr(VI) is the most relevant 
biologically.  Cr(VI)-induced DNA damage has been reported, including; oxidative stress 
induced damage, DNA inter-strand crosslinks, DNA-protein crosslinks, ternary adducts 
of Cr with the DNA backbone phosphate, phosphate-base crosslinks, abasic sites and 
DNA single- and double-strand breaks.  Since it is unlikely all of these damage forms are 
important to the ultimate mode of action of Cr(VI) toxicity, the subject of how Cr(VI) is 
mutagenic remains controversial. We have investigated the DNA damage response of 
DT40 cells to exposure to potassium chromate.  Our findings indicated a response pattern 
similar to hydrogen peroxide exposure and also strong sensitivity of mutants in the 
homologous recombination repair pathway.  The following assays were performed to 
investigate Cr(VI)-induced oxidative stress; NAD(P)H depletion, a neutral glyoxal gel 
electrophoresis assay, and the OTX-AGE assay – all for the determination of DNA SSB, 
as well as an MS assay for 8-oxo-dG.  None of these assays indicated levels above their 
respective controls that would suggest chromate-induced oxidative stress in DT40 cells.   
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The exquisite sensitivity found in the HR mutants, BRCA1, BRCA2 and RAD54 along 
with a lack of sensitivity in the FANCD2 mutant, indicates the possibility of DSB due to 
replication fork stalling, but suggests ICL are not involved in CR(VI) genotoxicity.  A 
strong sensitivity also seen in RAD9 and RAD17 but not ATM mutants, indicates that the 
ATR/ATRIP checkpoint pathway is stimulated when replication forks encounter Cr-DNA 
adducts – either ternary adducts or proposed microchelates of Cr with the phosphate and 
guanine.  Since the error-prone TLS polymerase, POLΖ, is known to participate after 
ATR-induced checkpoints, we propose that this may be the avenue to Cr(VI)-induced 
mutagenicity.              
 
Introduction 
Exposure to hexavalent chromium 
 Chromium is a naturally occurring element found in rocks, animals, plants, and 
soil. It can exist in several different forms. Depending on the form it takes, it can be a 
liquid, solid, or gas. The most common valence states are chromium(0), chromium(III), 
and chromium(VI) (Zhitkovich, 2005a; McCarroll et al., 2009).  The metal chromium,  
which is the chromium(0) form, is used for making steel. Chromium(VI) and 
chromium(III) are of the most significance biologically (Fishbein, 1976; Cohen et al., 
1993; Valko et al., 2005). Chromium compounds are used for chrome plating, dyes and 
pigments, leather tanning, corrosion inhibitors, fungicides, printing and reproducing and 
wood preserving (Fishbein, 1981; IARC Monograph vol.49, 1990).  The most important 
use of chromium is for alloying with other metals to make products such as stainless steel 
(Westbrook, 1979).  Chromium can be found in air, soil, and water after release from the 
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manufacture, use, and disposal of chromium-based products and is released from the 
burning of coal.  The Agency for Toxic Substances and Disease Registry estimated that 
in the United States, ~2,700-2,900 tons of chromium are emitted annually into the 
atmosphere and of this ~35% is Cr(VI) (ATSDR, 2008). Chromium has been found in at 
least 1,127 of the 1,699 current or former hazardous waste sites on the EPAs National 
Priorities List (ATSDR, 2008).  Chromium does not usually remain in the atmosphere, 
but is deposited into the soil and water. The forms of chromium in Superfund sites to 
which humans are most likely to be exposed are Cr(III) and Cr(VI) as dichromate 
(Cr2O72-), hydrochromate (HCrO4-) or chromate (CrO42-) depending on pH (Fig. 4-1) 
(Zhitkovich, 2005a).  Chromate is the primary anion at pH 7 whereas lowering the pH to 
6 leads to the predominance of hydrochromate.  Dichromate is found at negligible levels 
at physiological pH. Typical cations for Cr(VI) are sodium, potassium, calcium and 
ammonium (IARC Monograph vol. 49, 1990).  Of the two valence states, Cr(III) is 
considered to be moderately toxic while Cr(VI) is both very toxic and carcinogenic.  
Environmental exposure to Cr likely impacts millions of people drinking Cr-containing 
water, residing in the vicinity of numerous toxic sites, and various industrial users of Cr 
products.  In fact, Sedman, et al., have reported on a recent analysis that indicated that 
~38% of the municipal drinking water systems in California have detectable levels of 
hexavalent chromium (Sedman et al., 2006).Also, the presence of Cr in urban particulate 
matter and emissions from automobile catalytic converters leads to exposure by very 
large segments of populations in densely populated areas (Salnikow and Zhitkovich, 
2008). 
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 The general population is exposed to chromium (generally Cr(III)) through the 
ingestion of food and water, and inhaling air that contains the chromium compounds 
(ASDTR, 2008). People residing near chromium waste disposal sites or chromium 
manufacturing and processing plants have a greater probability of elevated chromium 
exposure than the general population and these exposures are generally to mixed Cr(VI) 
and Cr(III) (ASDTR, 2008). The average daily intake from air, water, and food is 
estimated to be less than 0.2 to 0.4 µg, 2.0 µg, and 60 µg, respectively (ASDTR, 2008). 
Dermal exposure to chromium may occur during the use of consumer products that 
contain chromium, such as wood treated with copper dichromate or leather tanned with 
chromic sulfate or through handling Cr contaminated soil, either directly by absorption 
through the skin or orally by eating or smoking with improperly washed hands (ASDTR, 
2008). 
 It has been previously reported that chromium induces cytotoxicity, oxidative 
stress, DNA damage, apoptosis and altered gene expression (Rudolf et al., 2006; Curtis et 
al., 2007).   Chromium induced carcinogenicity was first observed more than 100 years 
ago (Stern, 1982).  The United States Department of Health and Human Services, the 
United States Environmental Protection Agency, and the International Agency for 
Research on Cancer (IARC) have classified Cr(VI) compounds as human carcinogens 
based on increased incidences of lung cancers in workers in the chromium industry and 
its association with malignancies in lungs of rats exposed to the compounds by inhalation 
(IARC, 1990; Cohen et al., 1993; NTP, 1998).  Recent epidemiological and risk 
assessment studies have indicated up to a 25% lifetime risk of dying of lung cancer under 
the 52 µg/m3 permissible exposure limit (Gibb et al., 2000; Park et al., 2004).  This 
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standard, adopted by OSHA in 1971 has been lowered to 5 µg/m3 in 2006 (OSHA, 2006), 
but even with the new standard, an additional 10-45 deaths per 1000 exposed workers is 
expected.  
 
Absorption, distribution, metabolism and excretion of hexavalent chromium 
  Hexavalent chromium is absorbed after oral, dermal or inhalation exposure 
(Wahlberg and Skog, 1965; Wahlberg, 1970; Kerger et al., 1997; Mancuso, 1997).  
Gastrointestinal absorption of Cr(VI) is estimated to be less than 5% (USEPA Tox Rev, 
1998).  It has been demonstrated that contact of Cr(VI) with gastric juices significantly 
reduces absorption of the metal in the intestine (Sedman et al., 2006).  Contact with 
gastric juices has been found to reduce Cr(VI) to the trivalent form (Sutherland et al., 
2000).  A number of factors can influence the absorption of chromium following 
inhalation, including the size, oxidation state, and solubility of the chromium particles; 
the activity of alveolar macrophages; and the interaction of chromium with biomolecules 
following deposition in the lung (ATSDR, 1993). Water soluble chromate is absorbed 
rapidly by inhalation whereas insoluble compounds are less effectively absorbed.  
Cr(VI) is much more effectively absorbed into cells than Cr(III) due to its facilitated 
diffusion via non-specific anion channels since chromate ions, being tetrahedral,  
successfully mimic phosphate or sulfate ions (Zhitkovich, 2005a) .  
Chromium has been found widely distributed in the body after exposure to 
Cr(VI) in both human and animal studies (Coogan et al., 1991; Cohen et al., 1993; 
Mancuso, 1997).  Liver, kidney, spleen and bone were found to have the higher 
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concentrations (Sutherland et al., 2000).  Chromium has also been demonstrated to cross 
the placenta (Saxena et al., 1990). 
Ingested Cr(VI) is excreted primarily in the feces due to poor absorption while 
intravenously absorbed Cr(VI) is eliminated primarily in urine (Sayato et al., 1980).  
Hexavalent chromium is highly permeable into red blood cells where it binds with 
hemoglobin (Sayato et al., 1980; ).  Cr(III) is the biologically active form of the metal in 
the cell, although it is not readily absorbed.  The more readily absorbed form is the 
chromate ion which is easily absorbed through the non-specific ion channel (Alexander 
and Aaseth, 1995).  Human cells can accumulate Cr(VI) up to 30x the concentration 
existing outside the cell within 3 hr (Reynolds et al., 2007; Reynolds and Zhitkovich, 
2007; Sehlmeyer et al., 1990).  However, Cr(VI) itself is unreactive toward cellular 
macromolecules and must be actively reduced to the trivalent form (Salnikow and  
Zhitkovich, 2008).  Cr(VI) metabolism in mammalian cells does not require any 
enzymes and relies on the direct electron transfer from ascorbate and nonprotein thiols, 
such as glutathione and cysteine (Zhitkovich, 2005a).  Ascorbate accounts for about 
90% of the reduction of Cr(VI) to Cr(III).  Thus, the reduction of Cr(VI) to the  
thermodynamically stable Cr(III) (through Cr(V) and Cr(IV)) is the  activating step of 
chromium toxicity (Fig. 4-2) .  Variable amounts of Cr(V) and Cr(IV) may be present 
and the levels of each depend upon the reducing agent and ratio of reactants 
(Moghaddas et al., 1992; Stearn and Wetterhan, 1994; Lay and Levina, 1998).  When 
ascorbate is present in ≥2-fold molar excess to Cr(VI), a direct two-electron reduction to 
Cr(IV) occurs with Cr(V) being found only if ascorbate is present at a non-
physiologically low level (Stearn and Wetterhan, 1994; Lay and Levina, 1998; 
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Goodgame and Joy, 1987).  Thus, some believe it is doubtful that exogenous exposure to 
Cr(VI) could produce significant levels of Cr (V) (Salnikow and  Zhitkovich, 2008).  
Cysteine reduction of Cr(VI) occurs by two one-electron reductions to Cr(V) and then 
Cr(IV) (Quievryn et al., 2001).  Reduction of Cr(VI) by glutathione occurs mainly by an 
initial two-electron progression (O’Brien et al., 1992).  Cr(III) then readily forms 
coordination complexes with DNA and proteins (Salnikow and  Zhitkovich, 2008).  The 
coordination number of Cr(III) is six and all Cr(III) complexes have octahedral 
geometry (Zhitkovich, 2005a).  The ability of Cr(III) to form hexa-coordinate complexes 
makes the molecule thermodynamically stable and allows it to complex with H2O and 
other biologically important atoms (such as O, N and S) located on ascorbic acid, 
cysteine and glutathione which reduce Cr(VI) to Cr(III).  The rapid coordination of 
Cr(III) with any of these reducing agents is responsible for maintaining the solubility of 
Cr(III) at physiological pH.  Also, the ability to complex with N gives the ability to 
coordinate with DNA bases. 
 
DNA damage induced by chromium   
 Cr(III) is a hard Lewis acid and strongly prefers coordination to negatively 
charged oxygen groups (such as the one found on the phosphate in the DNA backbone) 
(Zhitkovich, 2005a).  The octahedral shape of the Cr(III) complex may have an influence 
on which DNA repair mechanism is chosen to repair interstrand cross-links caused by the 
complex.  NER would normally be chosen to repair crosslinks caused by bulky molecules 
that are planar (such B[a]P) and those that intercalate into the DNA strand, however the 
octahedral shape of the Cr(III) complex may cause distortions to the DNA helix that are 
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not recognized by NER enzymes.  The major adducts formed between DNA and 
chromium are ternary DNA-Cr-X cross-links with other molecules such as ascorbate, 
glutathione, cysteine and histidine (Fig. 4-3) (Zhitkovich et al., 1995; Quievryn et al., 
2002).  These ternary adducts are all formed via the attachment of Cr(III) to DNA 
backbone phosphates  (Zhitkovich et al., 1996; Quievryn et al., 2002).  Other phosphate-
linked Cr adducts have been proposed in which the phosphate is linked by Cr(III) to the 
N7 position of guanine forming a microchelate which has been suggested to be the 
mutagenic adduct while the ternary adduct may not be mutagenic (Fig. 4-4; Zhitkovich et 
al., 2001).  DNA-protein cross-links have also been identified in chromate treated cells, 
however, only at acutely cytotoxic concentrations (Costa, 1990; Costa et al., 1996) and 
are estimated to be less than 1% of all Cr-DNA adducts (Salnikov and Zhitkovich, 2008).   
 Small amounts of Cr(III) induced ICL have been detected during in vitro 
experiments after reduction of Cr(VI) by ascorbate or cysteine, but not by glutathione and 
the development of these ICL had a major dependence on the ratio of reducing agent to 
Cr(VI) (Zhitkovich et al., 2000; O’Brien et al., 2002; Bridgewater et al., 1994; ).  
However, ICL are difficult to rationalize from a steric standpoint due to the bulk of the 
octahedral Cr(III) complex, which is a highly polar moiety, and the need for the complex 
to invade the non-polar interior of the DNA helix (Zhitkovich, 2005a).  Therefore, it is 
probable that ICL induced by chromate occur only in vitro (Salnikov and Zhitkovich, 
2008). 
 Chromate-induced oxidative stress with resultant SSB have also been reported in 
the literature (Casadevall and Kortenkamp, 1995; Hassoun and Stohs, 1995; Bagchi et al., 
1997; Costa et al., 2002; Lee et al., 2004).  The theory is that under conditions of low 
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ascorbate, a single electron reduction of Cr(VI) could lead to significant levels of Cr(V).  
Cr(V) has been shown to act as a catalyst in Fenton-like reactions with H2O2 to produce 
hydroxyl radicals (Molyneux and Davies, 1995).  These ROS can induce SSB either by 
direct attack at the sugar-phosphate backbone or indirectly as a result of BER of oxidative 
base damage (Friedberg et al., 2006).        
 Cell culture and in vivo studies of chromium toxicity have been reporting 
evidence, such as increased chromosomal breaks (Wise et al., 2003; Xie et al., 2009) and 
micronuclei (Seoane et al., 2001), implicating the existence of DSB. Only recently has 
more direct evidence of DSB been demonstrated (Reynolds et al., 2007; Ha et al., 2004).  
DSB are induced indirectly after cells pass through S-phase and in conjunction with 
mismatch repair (MMR) proteins (Salnikow and Zhitkovich, 2008).  One aspect of 
Cr(VI) related cancers is the presence of microsatellite instability (Hirose et al., 2002) 
which suggests a loss of functional MMR (Kunkel et al., 2005; Modrich, 2006).  This 
Cr(VI)-induced microsatellite instability was then associated with the loss of expression 
of the essential MMR protein MLH1 (Takahashi et al., 2005).  This absence of a 
functional MMR pathway leads to the inability of cells to repair replication errors 
resulting in significantly increased mutation rates and consequently leading to the 
expression of a mutator phenotype caused by the inability to avoid future mutations, even 
without continued Cr exposure (Salnikow and Zhitkovich, 2008).  Also, MMR-deficient 
human cells have been reported to be resistant to clonogenic lethality induced by Cr(VI) 
(Reynolds and Zhitkovich, 2007) as well as having an abrogated cellular ability to inhibit 
replication in the presence of Cr-DNA adducts (Reynolds et al., 2007; Peterson-Roth et 
al., 2005).  Therefore, based on these findings, it is apparent that MMR may be required 
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for processing Cr-DNA adducts into DSB and this has led to the proposal of a model in 
which chronic exposure to toxic doses of Cr(VI) leads to the clonal selection of resistant 
cells deficient in MMR (Peterson-Roth et al., 2005; Zhitkovich et al., 2005b).  
 Our hypothesis in this aim has been that phosphate-linked Cr(III) adducts are 
causing replication fork stalling which, in turn, is leading to DSB which need HR for 
their repair and that oxidative stress induced by Cr(VI) is not important to the overall 
genotoxic effects of Cr(VI).  To investigate this  proposition we have endeavored to make 
use of the DT40 cell system using the multi-well plate based system developed in 
Specific Aim 1 to ascertain which DNA repair pathway(s) are used to tolerate damage 
induced by Cr(VI) (as potassium chromate).  Also, to further assess the DNA damage 
response to Cr(VI), we have employed several other assays to evaluate the levels of 
oxidative stress and DNA SSB induced in cells after exposure to Cr(VI).  These include 
measurement of 8-oxo-dG by ultra high pressure liquid chromatography-heat assisted 
electrospray ionization-tandem mass spectrometry (UPLC-HESI-MS/MS), an NAD(P)H 
depletion assay to assess SSBs, glyoxal gel electrophoresis (GGE) and O-(tetrahydro-2H-
pyran-2-yl)hydroxylamine agarose gel electrophoresis (OTX-AGE), also to measure 
SSBs, and a DNA fiber spread methodology whereby the state of cellular replication can 
be monitored.  
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Materials and Methods 
 
Cell culture 
 DT40 cells were cultured and maintained as described in Chapter I.  
Exponentially growing cells with an approximate concentration of 1x106/mL were used 
for each experiment described hereafter in this chapter. 
DT40 multi-well cell survival assay 
 The DT40/XTT multi-well plate survival assay was performed as described in 
Chapter I and nearly the full complement of mutants was used.  Cells were exposed to a 
continuous treatment of potassium chromate (K2CrO4) dissolved in molecular grade 
sterile water.  Chromate concentrations were 0, 0.094, 0.188, 0.375, 0.75, 1.5 and 3 µM 
and the dilutions were kept at room temperature until used.  Control and blank wells 
received sterile water.  Growth was continued under the prescribed conditions until the 
cells in the control wells were nearly confluent (3 – 4 days).  The plates were then 
exposed to XTT, allowed to incubate 3 – 4 h and read on a plate reader either 
immediately or after storage in plastic bags at 4 °C. 
 
Larger-scale exposure method 
 When it has become necessary to expose DT40 cells on a larger scale for the 
purpose of DNA extraction, the exposures have been performed in 20 mL complete 
medium in 10 cm sterile dishes.  Cells for these experiments were grown overnight so as 
to reach a cell concentration of 1x106/mL and also be in an exponential growth phase.  
After the desired treatment, cells were collected, centrifuged at 1100g for 5 min and 
washed 3x in ice cold PBS or ice cold 20 mM 2,2,6,6-tetramethylpiperidine-N-oxyl 
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(TEMPO) if the assay being performed was investigating oxidative stress or DNA SSB.  
Although DT40 cells grow suspended in the medium, it was found that some cells will 
attach and that scraping the dish will significantly increase the number of cells collected.  
After the last wash, cells were pelletized and stored in a small amount of PBS or TEMPO 
at -80 °C prior to DNA extraction. 
 
DNA extraction 
  DNA extractions were performed using the PureGene DNA extraction kit with a 
previously described modification (Nakamura et al., 2000).  Briefly, thawed cell pellets 
were lysed in lysis buffer supplemented with 20 mM TEMPO as a radical scavenger.  
Protein was precipitated with the protein precipitation solution provided in the kit after 
which the DNA/RNA mixture was precipitated from the supernatant with isopropyl 
alcohol.  The DNA/RNA pellet was then resuspended in lysis buffer containing 10 mM 
TEMPO and incubated with RNase T1 (50 unit/mL) at 37 °C for 30 min, followed by 
precipitation of protein and DNA.  The DNA pellet was resuspended in sterilized distilled 
water with 1 mM TEMPO and stored at -80 °C. DNA concentration was determined 
using a UV spectrophotometer. 
 
Potassium chromate acute Toxicity analysis in DT40 cells 
 To analyze the level at which acute toxicity occurs after treatment with Cr(VI) we 
exposed DT40 parental cells to 0, 9.4, 18.8, 37.5, 75, 150 and 300 µM concentrations of 
potassium chromate for 4 h under standard DT40 incubation conditions.  Exposure took 
place in 10 cm dishes with ~0.6x106 cells/mL in 20 mL complete medium.  After 4 h, cell 
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counts to determine the level of cell proliferation were performed on each sample dish 
using a hemacytometer and trypan blue dye.  Results were reported as a percentage 
increase in cell count over the initial seeding.  
 
Assay for level of 8-oxo-dG 
 The UPLC-HESI-MS/MS method previously described (Boysen et al., 2010) has 
been used for the determination of 8-oxo-dG contained in DT40 cells after exposure to 
potassium chromate at concentrations of 0, 30 and 60 µM for 4 h using the larger-scale 
exposure method described above.  DT40 parental cells were also exposed to 80 µM 
H2O2 for 0.5 h for use as a positive control.  The DNA was extracted by the method 
described above, quantitated by UV spectrometry and stored at -80 °C until used for the 
assay. 
 Briefly, after addition of 500 fmol of [15N5]8-oxo-dG the DNA is hydrolyzed with 
DNAse I followed by phophodiesterase I with alkaline phosphatase.  The enzymes were 
removed by ultra-filtration using pre-washed YM-10 microcentrifuge filters (Millipore, 
Bedford, MA).  The 8-oxo-dG was then purified from the DNA filtrates by reverse phase 
HPLC using an Ultrasphere ODS C18 4.6mm×250mm 5 µm column (Beckman, 
Fullerton, CA) on an Agilent 1200 HPLC system (Agilent, Santa Clara, CA).  Solvents 
were removed with a SpeedVac concentrator and samples were stored at −20 °C until 
analysis by UPLC–HESI–MS/MS.  The quantitative analysis of 8-oxo-dG was performed 
with a UPLC (Waters, Milford, MA) coupled to a TSQ-Quantum Ultra triplequadrupole 
mass analyzer (ThermoFinnigan, San Jose, CA) using an HESI source.  
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Glyoxal Gel Electrophoresis 
 DT40 parental cells were exposed using the larger-scale exposure method for 4 h 
at an initial cell concentration of 1x106 cells/mL.  Concentrations of potassium chromate 
were 0, 30, and 60 µM.  The cells were also exposed to 1 mM methyl methanesulfonate 
(MMS) to provide for a positive control.  The Lambda DNA-HindIII Digest (New 
England Biolabs, Ipswich, MA) was used as a marker (5 µg).   
 The neutral GGE assay was used to fractionate genomic DNA SSB according to a 
previously described method, albeit with modification (Drouin, et al., 1996; Pachkowski, 
et al., 2009).  Briefly, equal amounts of DNA (3 – 10 µg) from samples to be compared 
were denatured in 1.5 M glyoxal, DMSO (50% v/v) and 10 mM sodium phosphate buffer 
(pH 7) for 1 h at 50 °C.  Loading buffer, consisting of 50% glycerol, 0.01% bromophenol 
blue, 0.01% xylene cyanol and 10 mM sodium phosphate buffer (pH 7), was added to 
each sample prior to loading onto 0.7% agarose gel  in 10 mM sodium phosphate running 
buffer (pH 7).  All reagents with the exception of the loading buffer were made fresh for 
each day of an experiment.  The gels were electrophoresed at -4 °C for 15 h at 25v.  Gels 
were stained with acridine orange (5 µg/mL) for 1 h and de-stained with de-ionized water 
until background staining was reduced to an acceptable level. Imaging was performed on 
a Kodak Image Station 440CF system. 
 The gel lane images obtained were similar to the images acquired from a Comet 
assay.  Thus, the GGE images were assessed using the image analysis procedure 
normally used for the Comet assay (CometScoreVersion 1.5, Tritek).  The high molecular 
weight DNA appearing above the 23.1 kb marker in the GGE analysis was equated with 
the DNA retained in a comet head.  Correspondingly, the DNA smear produced by the 
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GGE represents the comet tail and the extent of the DNA migration represents the 
amount of SSB present in each case.  The SSB content is represented by a tail moment 
calculated as the product of the tail length and percentage of DNA in the tail.  Higher tail 
moment values suggest a greater amount of DNA damage in the form of SSB. 
 
OTX-AGE Electrophoresis 
 DT40 cells with identical exposures to the GGE were used for this assay.  A 
modified AGE protocol (Drouin, et al., 1996) was performed to assess SSB in DNA from 
cells exposed to potassium chromate and MMS.  Agarose gel (0.7%) was prepared in 50 
mM NaCl and 1 mM EDTA (pH 7).  After setting, the gel was immersed in mild running 
buffer (30 mM NaOH, 1 mM EDTA, pH 12.4) for at least 30 min.  Equal quantities of 
DNA (3-5 µg) in 50 mM HEPES buffer were incubated for 1 h at 37 °C in the presence 
or absence of OTX (Aldrich).  Afterward, the samples were denatured with alkaline 
buffer (100 mM NaOH, 30 mM OTX, 50 mM HEPES, pH 12.8) for 20 min at 37 °C.  
Loading buffer (10 mM NaOH, 95% fomamide (Fluka), 0.05% bromophenol blue, 0.05% 
xylene cyanol), was added to the samples which were then loaded onto the agarose gel.  
The gels were electrophoresed at -4 °C for 15 h at 30v after which the gel was treated 
with neutralization buffer (400 mM Tris, pH 7.5) for 20 min at room temperature.  The 
gels were stained with acridine orange (5 µg/mL) for 1 h followed by de-staining in de-
ionized water.  Imaging of the gels was performed on a Kodak Image Station 440CF 
system.  The gels were then analyzed using the same method as described for the GGE 
assay above. 
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DT40 DNA fiber spread analysis 
Cell preparation and treatment 
 The DT40 cells parental cells were used and maintained in logarithmic growth to 
obtain a concentration of approximately 1x106 cells/mL on the day of the experiment.  
Extra dishes of cells were grown so that those cells could be removed by centrifugation 
and the used medium collected and stored at 39.5 °C for use in the experiment.  Cells 
were added in the amount of 3.6 mL to the wells of a 6-well plate after which was added 
3.6 µL (1000x dilution in medium) of iodo-deoxyuridine (IdU).  The cells were incubated 
for 5 min at 39.5 °C for 5 min and then centrifuged for 5 min at 1100g (10 min total 
exposure time).  The medium was then aspirated from the cells.  Used medium plus 
potassium chromate (30 µM in a total of 4 mL) was then added to the cell pellet which 
was then re-suspended and incubated as above for a total of 15 min (the last 5 min being 
during the centrifugation).   The medium was then aspirated, the cells washed in PBS and 
then quickly centrifuged (~2 min) and the PBS aspirated.  The cells were then re-
suspended in used medium with a final pulse of chloro-deoxyuridine (CldU) for a 20 min 
incubation (once again including a 5 min incubation).  The medium was aspirated and the 
cells were re-suspended in 5 mL ice cold PBS.  After a final centrifugation of 5 min the 
cells were re-suspended to obtain a count of 100 – 200 cells/µL. 
 
DNA Fiber Spread Analysis 
 The DNA fiber-labeling procedure used was originally described by Merrick, et 
al., and modified by Chastain et al. and Unsal-Kacmaz et al. (Merrick et al., 2004; 
Chastain et al., 2006; Unsal-Kacmaz et al., 2007).  Briefly, 2 µL cells were applied in a 
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line across silane-prep slides and allowed to dry to tackiness.  The cells were overlaid 
with lysis buffer for 10 min after which the slides were placed at a 25° angle and allowed 
to dry for a minimum of 4 h.  The slides were then fixed in 3:1 methanol:acetic acid for 2 
min and stored at -20 °C for a minimum of 24 h.  The slides were then treated with 2.5M 
HCl, washed 1x with PBS/Tween and 2x with PBS, and blocked in 3% BSA in PBS for 
30 min at RT.  Next, the slides were incubated with 100 µL of the 1° antibodies (mouse 
α-BrdU, rat α-BrdU) for 1 h at room temperature.   After being placed in stringency 
buffer for 10 min, the slides are washed 3x in PBS for 30 min at RT and blocked in 3% 
BSA once more.  A second incubation with 100 µL of the 2° antibodies  (Alexaflour 594-
conjugated rabbit α-mouse,  Alexaflour 488-conjugated chicken  α-rat) was performed 
after which the slides were washed 3x in PBS followed by blocking in 2% goat serum in 
PBS for 30 min.  Incubation with 100 µL of the 3° antibodies (Alexaflour 594-conjugated 
goat α-rabbit, Alexaflour 488-conjugated goat α-chicken) for 30 min at room temperature 
came next.  The slides were washed 3x in PBS and cover-slipped with anti-fade from 
Invitrogen.  After staining, the slides are imaged on a confocal microscope after which 
the labeling patterns on the combed DNA are marked and scored. 
 
Determination of intracellular NAD(P)H after treatment with potassium chromate 
 The level of intracellular NAD(P)H was measured by a method originally 
described by Nakamura et al., (Nakamura et al., 2003) and later modified (Takanami et 
al., 2005).  Cells (5 x 103) in complete medium were seeded into a 96-well plate and 
allowed to incubate over night.  The cells were then treated with potassium chromate or 
MMS at the indicated concentrations.  The NAD(P)H level was determined at time 0 and 
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every one half hour after for 4 h.  At the same time the cells were also incubated with 0.5 
mM XTT and 0.02 mM PMS.  At the prescribed times, the formazan dye formation was 
read on a plate reader at 450 nm referenced to 650 nm.  The absorbance values for the 
exposed wells were then compared with those of controls.  Each test was performed with 
and without the PARP inhibitor 3-aminobenzamide (3-AB; 20 mM). 
 Statistical analysis 
 For the determination of statistical significance between controls and test sample 
values, a Student’s t test was performed for each of the mutant results in each of the DNA 
repair response tests and for the potassium chromate acute toxicity analysis in DT40 cells. 
 
Results and Discussion 
Role of homologous recombination repair and non-homologous end-joining repair of 
DNA damage induced by potassium chromate. 
 The DNA damage induced by Cr(VI) (as potassium chromate) has been evaluated 
for the contribution each DNA repair pathway devotes to tolerance of that damage.  The 
DT40/XTT cell survival assay previously described was used for this evaluation.  The 
data indicate that DT40 cells deficient in HR repair proteins display strong sensitivity 
when exposed to Cr(VI).  The HR repair pathway mutants showed sensitivity to Cr(VI) in 
the following order: BRCA1 >> RAD54 > BRCA2 >> FANCD2 ~ DT40 parental cells 
(Fig 4-5).  The hypersensitivity of BRCA1 along with the strong sensitivity of RAD54 
and BRCA2 indicate that the HR pathway plays an important role in the repair of damage 
induced by chromate and would appear to indicate the possibility of DNA double-strand 
breaks induced by chromate which is in agreement with a recent report (Stackpole et al., 
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2007).  The lack of sensitivity of FANCD2 would seem to rule out DNA inter-strand 
crosslinks or DNA-protein crosslinks. The NHEJ deficient cells exposed to Cr(VI) 
exhibited mixed results with the following sensitivities: Ku70 > LIGIV > DNAPKcs = 
DT40 parent cells (Fig 4-5).  The ATM knockout showed no sensitivity (p = 0.23) to 
exposure to chromate.  ATM is a DNA damage sensor protein responsible for sensing 
DNA double-strand breaks and, along with the Mre11/Rad50/Nbs1 (M/R/N) complex 
and BRCA1, is indispensable for the activation of the intra-S checkpoint (Sancar et al., 
2004).  Taken together, these results reveal that while DSB may not be involved in this 
process (lack of ATM sensitivity), HR proteins are, nonetheless, protecting the cell from 
damage by chromate.  The significant sensitivity of the NHEJ mutants also suggests a 
role for that damage pathway in the tolerance of chromate damage.  The NHEJ deficient 
cell sensitivity agrees with a recent report of similar sensitivity in yeast, however, it 
should be noted that the concentrations used in that study were approximately 10,000 fold 
the concentrations used here (~25 mM vs. ~2 µM; Santoyo and Strathern, 2008).  Thus, 
our evidence represents the first report of NHEJ deficient cell sensitivity at biologically 
relevant concentrations.  
 
The contribution of the excision repair (BER/NER) pathways to the repair of DNA 
damage induced by potassium chromate. 
 Several reports have indicated that Cr(VI) induces adducts with the phosphate 
group of DNA (Zhitkovich et al., 1995).  As mentioned above, these adducts are mostly 
ternary DNA-Cr-X adducts where X = glutathione, cyteine, histidine or ascorbate.  These 
adducts form through attack on DNA by preformed ligand-Cr(III) bi-dentate complexes 
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(Zhitkovich et al., 1995), and probably constitute about 90% of all Cr-DNA adducts.  The 
DNA-Cr-X adducts have been reported to be nonmutagenic (Salnikov and Zhitkovich, 
2008).  The remaining 10% of the adducts are reported to be mutagenic and are 
postulated to be phosphate-N7-dG microchelates (Zhitkovich et al., 2001; Arakawa et al., 
2000; Fig 4-4) which would be likely substrates for NER.  To investigate this reported 
aspect of Cr adduction we once again employed our DT40 mutants deficient in both BER 
and NER.  Our results show sensitivity in the following order: FEN1 > PARP1 >> XPA 
> POLB ~ DT40 parental cell (Fig. 4-6).  The POLB mutant consistently showed survival 
rates nearly identical to the parental cells suggesting the possibility BER plays no role in 
chromate DNA damage tolerance, however, this cannot completely rule out BER as a 
chromate induced damage repair pathway due to the existence of backup polymerases for 
POLB (such as POLL and POLQ; Tano et al., 2007; Yoshimura et al., 2006).  Our result 
for POLB agrees with O’Brien, et al., who found no inhibition of Cr(III) repair synthesis 
after treatment with the POLB inhibitor, 2,3-dideoxythymidine triphosphate (O’Brien et 
al., 2005).  The higher sensitivity of the PARP1 deficient cells may be explained by the 
participation of this enzyme in DNA replication and double-strand break repair. Although 
FEN1 has traditionally been thought of as a BER long-patch pathway 5′-endonuclease, 
studies have found that the protein is involved in the degradation of RNA primers in 
Okazaki fragments during replication  (reviewed in Liu et al., 2004, and Burgers, 2009).  
Therefore, we may be expected to find sensitivity in FEN1 mutants because this cell line 
spends so much time in S-phase.  Indeed, we have found this protein deficiency to show 
sensitivity in other studies (such as with acrolein) we have done for which no BER 
activity was suspected.  Surprisingly, our results for the XPA mutant show only mild but 
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significant sensitivity to Cr(VI) exposure, with an LC50 rate of 76% of that for the 
parental cells.  This lack of hypersensitivity in XPA mutants may be attributable to the 
finding mentioned previously that ~90% of Cr adducted DNA is in the form of 
preferentially bound Cr(III) to the phosphate backbone that only create 1-2° distortions in 
DNA duplexes (Blankert et al., 2003).  Such small distortions may not be readily 
recognized by the NER pathway that normally requires distortions greater than 20%.  
Therefore, the sensitivity we have observed may be due to the remaining 10% of Cr-
DNA adducts which are microchelates between the phosphate and N7 of dG. 
 
Result of acute toxicity test of DT40 parental cells exposed to potassium chromate. 
 We needed to determine the level at which sub-lethal but significant sensitivity 
occurs with Cr(VI) treatment of DT40 cells.  This was necessary so that DNA could be 
extracted from these cells for the purpose of performing other tests such as those for the 
determination of oxidative stress and SSB.  Cells were continuously exposed to 
increasing doses of potassium chromate for 4 h as described above. As a result, it was 
determined that the lowest of our potassium chromate concentrations showing significant 
sensitivity was 37.5 µM (p > 0.0004) (Fig. 4-7). 
 
The role of oxidatively induced genotoxicity due to exposure to Cr(VI) in DT40 cells. 
 There have been several reports espousing the notion that Cr(VI) induces 
oxidative stress-related DNA damage, mostly due to the production of oxygen radicals 
during the intracellular reduction of Cr(VI) to Cr(III) (Hassoun and Stohs, 1995; 
Casadevall and Kortenkamp, 1995; Costa et al., 2002; Lee et al., 2004; Slade et al., 2005; 
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Hailer et al., 2005).  Other reports have shown that an increase of DNA SSBs occurs after 
treatment with Cr(VI) (Sugiyama et al., 1986; Bagchi et al., 1997; Hodges et al., 2001; 
Dana Devi et al., 2001; Gambelunghe et al., 2003;) which further implicates oxidative 
stress as at least one route of genotoxicity generated by Cr(VI).  In fact, our own DNA 
damage response data resulting from DT40 BER and NHEJ mutants exposed to H2O2 
reveal a pattern similar to that obtained with hexavalent chromium.  Consequently, we 
elected to investigate further the role of oxidative stress induced genotoxicity in DT40 
cell.  To assess the level of oxidative stress, we made use of four assays at our disposal: 
8-oxo-dG levels determined by mass spectrometry to directly look for those lesions 
which are typically associated with oxidative stress and three DNA single-strand break  
assays; the NAD(P)H depletion assay, the GGE assay, the OTX-AGE assay.  Every 
report we have encountered to date indicating SSB induction by Cr(VI) have made use of 
assays (either an alkaline Comet or alkaline elution) that require alkaline conditions 
which are known to cause artifactual DNA SSB in the presence of adducts involving the 
DNA backbone (such as the DNA-Cr-X adducts that are thought to make up the majority 
of all adducts of Cr with DNA).  Thus, the choice of the two electrophoretic agarose gel 
assays: 1) the GGE assay performed at physiological pH; and, 2) the OTX-AGE assay 
which is performed at alkaline pH but uses the hydroxylamine, OTX, to protect abasic 
sites from β-elimination at the deoxyribose which would result in artifactual strand 
breaks if not protected.  The OTX-AGE assay has the added benefit of providing the 
ability to indirectly assess the presence of abasic sites by operating the test with and 
without OTX.  The NAD(P)H depletion assay serves as a surrogate for NAD+ 
consumption, an indicator of PARP1/2 activation resulting from SSB formation. 
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Result of 8-oxo-dG assay after exposure to chromate. 
 Results from the mass spectrometric assay for 8-oxo-dG exposed to chromate are 
depicted in Fig. 4-8.  Statistical analysis has indicated no significant difference in the 
response between the 30 and 60 µM chromate exposed cells and the controls whereas the 
H2O2 exposed cells showed a very significant increase in the 8-oxo-dG level. 
  
Result of NAD(P)H depletion assay for SSB 
 Poly(ADP-ribose) polymerase-1 (PARP-1) is a protein modifying enzyme used in 
BER that seeks out and binds to SSB and subsequently synthesizes polymeric adenosine 
diphosphate-ribose (PAR) that is appended to both PARP-1 itself and other proteins 
involved in DNA metabolism.  This adduction of PAR to DNA metabolic proteins, such 
as topoisomerase, histones and DNA replication factors, has been proposed to be an 
important function in the repair of SSB as well as in BER and may limit genotoxic stress 
during these repair processes (Boothman et al., 1994; Trucco et al., 1998; Woodhouse et 
al., 2008;).  During the production of PAR, significant amounts of NAD+ are consumed 
as a source of ADP-ribose (Schreiber et al., 2006).  Thus, the NAD(P)H depletion assay 
has been developed to serve as a surrogate for NAD+ consumption and an indicator of 
PARP-1 activation due to SSB (Nakamura et al., 2003).  
 As has been previously shown and we have repeated here, exposure of DT40 
parental cells to MMS triggers the accumulation of SSB as intermediates of BER which 
leads to PARP-1 activation with NAD+ consumption and depletion of NAD(P)H (Fig. 4-
9B; Pachkowski et al., 2009).  Co-exposure to both MMS and the PARP inhibitor, 3-AB, 
protected against NAD(P)H depletion indicating that PARP-1 is active in response to 
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MMS exposure (Fig. 4-9B).  The same experiment, repeated with potassium chromate at 
exposures up to and including 120 µM, a concentration which is significantly genotoxic, 
demonstrated no significant difference between 3-AB treated and untreated cells (Fig. 4-
9A).  This result presents a strong indication that SSB are not being induced in significant 
measure by Cr(VI) exposure in DT40 cells. 
  
Result of GGE assay for SSB  
 Methods utilizing alkaline conditions have been traditionally used for the purpose 
of quantitating SSB.  However, these methods are not suitable for separating direct strand 
breaks from those induced during the procedure due to the lability of abasic sites and 
oxidatively modified bases in alkaline conditions (Drouin et al., 1996). The glyoxal 
agarose gel electrophoresis method, initially described by Carmichael and McMaster for 
use on single-stranded RNA, is performed in neutral conditions using glyoxal and DMSO 
for denaturation of genomic DNA (Carmichael and McMaster, 1980).  Glyoxalation of 
DNA allows the strands to remain denatured during electrophoresis and the 
electrophoretic mobility of glyoxalated DNA is due to frank strand breaks and not to the 
presence of abasic sites or modified bases (Drouin et al., 1996).   For the GGE assay, we 
treated parental DT40 cells with 0, 30, and 60 µM concentrations of potassium chromate 
for 4 h.  As indicated previously by our acute toxicity assessment, 60 µM exposure 
should be significantly toxic for the purpose of inducing SSB if this type of damage is 
caused.  Parental cells treated for 3 h with 1 mM MMS were used as a control.  As can be 
seen in Fig. 4-10, there is no significant indication of SSB at the 30 and 60 µM level of 
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chromate treatment above that of the controls.  Thus, Cr(VI) does not produce 
inducement of SSB when assayed under neutral conditions. 
 
Result of OTX-AGE assay for SSB 
 DT40 cells for this assay were exposed in the same manner as in the GGE assay.  
The results (Figs. 4-11,12) indicate no significant difference between the 30 and 60 µM 
chromate treatment and the control regardless of the addition of OTX in the assay.  The 
average of the percentages of DNA in the tails of the control and 60 µM chromate treated 
samples were 22% and 21%, respectively.  Also, the average results for the OTX- and 
OTX+ treated 60 µM chromate exposed samples were nearly identical, indicating a lack 
of a significant numbers of abasic sites induced by chromate.  Interestingly, in every 
sample pair but one on our gels, the OTX untreated sample did show an increase of SSB 
development during the assay indicating that alkaline conditions can overestimate the 
level of SSB formation if the DNA is not protected. 
  
Result of DNA fiber spread analysis of DNA exposed to potassium chromate 
 Our DT40 survival data that relates to the HR and NHEJ DNA damage repair 
pathways indicates the possibility DSBs as a result of replication forks stalling upon 
contact with damage caused by chromate.  To assess the affect of chromate exposure on 
DNA replication we conducted a process known as the DNA fiber spread (aka 
“combing”) analysis which allows the visualization of the different stages of replication.  
Logarithmically growing DT40 cells were pulsed with IdU, exposed to potassium 
chromate at various concentrations (0, 15, 30, 60 and 120 µM), and then pulsed with 
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CldU.  Approximately 400 cells were applied to a glass slide and treated with lysis buffer 
after which the slides were placed at an angle causing the DNA fibers to form straight 
rows (combing).  The slides were then fixed.  Immunostaining with fluorescent 
antibodies (AlexaFlour 594 for IdU and Alexaflour 488 for CldU) was then performed to 
detect the presence of the halogenated uracil with red staining indicating IdU and green 
staining CldU.  The replication tracks were then detected by fluorescence microscopy and 
scored manually (Fig. 4-12).  This technique allows for the determination of the status of 
replication by making it possible to distinguish between ongoing replication forks 
(elongation, labeled red/green), newly fired replicons (initiation, labeled green only), and 
prematurely stalled replication forks (labeled red only; Fig. 4-13; Merrick et al., 2004).  
 As can be observed in Figures 4-14,15 exposure to chromate appears to have a 
distinct effect on replication in wt DT40 cells, especially with respect to the inhibition of 
new origin firing at the higher Cr(VI) concentrations.  A more modest effect was 
observed for replication terminations after Cr exposure and this effect was directly dose 
dependent.  The most striking result from the DNA combing assay may be noticed in 
Figure 4-16, which indicates the slowing of replication forks, as evidenced by the 
decreasing relative length of green to red in red/green tracks.  Replication fork slowing 
also was seen as dose dependent.  Two distinct possibilities may be considered for these 
observations.  First, the replication terminations and the slowing of the replicons are most 
likely due to the same cause – replication forks encountering Cr-DNA adducts.  The 
observed terminations in the assay represent stalled forks at locations where repair of the 
adducts has not taken place while the slowing most likely is evidence of a fork that has 
stalled but continued after a repair action and replication fork recovery.  Second, the 
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reduction in green-only tracks is an indication that an intra-S checkpoint has been 
triggered by the higher Cr concentrations.  
 
Discussion 
 As depicted in Figure 4-17, hexavalent chromium has been proposed in the 
literature to induce numerous types of damage involving several different metabolic 
pathways.  Still, the process by which Cr(VI) is mutagenic is hotly debated with a 
copious amount of new reports in the literature each year.  Of all types of damage 
indicated in Figure 4-17, the two receiving the most attention in recent reports are 
oxidative stress induced damage and adducts to the DNA backbone. We felt that we 
could make a useful contribution to this body of work by exploiting the isogenic DT40 
cell system and other modern techniques such as neutral single-strand break analysis, 
DNA fiber spread analysis and the NAD(P)H depletion assay for single-strand breaks, as 
well as others. 
 We first employed the DT40 survival method to determine which DNA repair and 
checkpoint pathways are involved in the tolerance of damage induced by potassium 
chromate.  These data have revealed an exquisite sensitivity in mutants, with the 
exception of FANCD2, of the HR repair pathway as well as a more moderate sensitivity 
in the NHEJ pathway – both of which are employed by cells to repair DNA DSBs.  These 
outcomes would suggest strongly that chromate is inducing DSBs if it were not for the 
result obtained from the ATM DT40 knockout which failed to reveal any significant 
sensitivity to Cr.  ATM is a checkpoint-specific damage sensing protein required for 
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detecting DSB.  Lack of sensitivity in the ATM mutant would therefore lead us away 
from a conclusion that Cr genotoxicity is a result of DSB. 
 Interesting, we did find that other damage sensors, Rad17 and Rad9, are quite 
sensitive and moderately sensitive respectively.  This data implies that an alternative 
intra-S checkpoint, the ATM and Rad3 related/ATR-interacting protein (ATR/ATRIP)-
mediated pathway has been activated in response to chromate exposure.  When DNA is 
damaged by UV or experiences base damage by chemicals that create bulky base lesions 
(such as the proposed DNA-Cr-X ternary lesions) the chief damage sensor is the 
ATR/ATRIP heterodimer (Abraham, 2001; Cortez et al., 2001) which is recruited to 
RPA-coated ssDNA in the vicinity of the stalled replication fork and becomes activated.  
Other complexes which are recruited to this region include the checkpoint clamp loader 
complex, 9-1-1 (Rad9/Rad1/Hus9) complex, the Rad17-RFC complex, and the protein 
claspin.  The presence of these complexes together leads to the phosphorylation and 
activation of the proteins Chk1, BRCA1 and Nbs1 by ATR (Tibbets et al., 2000; 
reviewed in Osborn et al., 2002).  Activated Chk1 then phosphorylates Cdc25A which 
leads to the inactivation of the Cdk2/Cyclin2 E complex resulting in inhibition of 
replication origin firing and S-phase delay (Heffernan et al. 2002).  Our DNA fiber 
spread results showing the slowing of replication, an increase in terminations and a 
decrease in new origin firing tends to support the notion that this process has been 
initiated.  Phosphorylation of BRCA1 and Nbs1 by ATR is necessary for the recovery of 
stalled, regressed or collapsed replication forks (Sancar et al., 2004), therefore, the 
hypersensitivity of our BRCA1 mutant should not be surprising.  Studies in yeast have 
shown that certain recombination proteins, such as Rad51 and the Mre11/Rad50/Nbs1 
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(M/R/N) complex, and TLS polymerases such as polymerase ζ (REV3), are involved in 
the recovery of stalled replication forks (Haber  and Heyer, 2001; Kai and Wang, 2003).  
Polζ is  known to be responsible for both error-free and error-prone translesion bypass 
and can induce mutagenesis resulting from the processing of UV damage, abasic sites and 
TLS through chemically damaged bases (reviewed by Prakash et al., 2005). O’Brien, et 
al., in a recent study in yeast, found that TLS (Polζ or Polη) deficiency had little impact 
on clonogenic cell survival or cell growth, but rev3 yeast displayed attenuated Cr(VI)-
induced mutagenesis (O’Brien et al., 2009).  Not surprisingly, our REV3 DT40 mutants 
also showed little sensitivity to Cr(VI).  Thus, one possible scenario for the mutagenicity 
of hexavalent chromium can be suggested from our results: 1) DNA-Cr-X ternary adducts 
are formed during the S-phase of the cell cycle; 2) replication forks encounter these 
lesions and stall, regress or collapse requiring HR proteins to aid in restarting; 3) the 
intra-S checkpoint is initiated by the ATR/ATRIP pathway resulting in inhibition of 
replicon firing and delay of replicating forks; 4) in the meantime, Polζ, in an error-prone 
process, may be called upon resulting in a mutagenic progression leading to a mutator 
phenotype and eventually to cell transformation.  
 We next wished to assess the possibility that Cr(VI) exposure induces oxidative 
stress as an alternative route to genotoxicity.  As 8-oxo-dG is considered to be an 
important marker of oxidative stress, we assayed for that adduct using a state of the art 
mass spectrometric method developed in our laboratory (UPLC-HESI-MS/MS).  No 
significant level of 8-oxo-dG was found above background in this analysis.  To further 
investigate the possibility of oxidative stress, we employed an NAD(P)H depletion assay, 
also developed in our laboratory.  This assay represents a very sensitive, albeit indirect, 
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method for the determination of SSB (which should be present as a result of oxidation of 
DNA bases).  This assay failed to reveal any significant difference of NAD(P)H depletion 
between the control and the Cr(VI) treated cells.  Finally, we employed two different 
types of agarose gel electrophoresis methods, also in an attempt to find SSB induced by 
Cr(VI) exposure.  The GGE assay, performed under neutral conditions, indicated no 
increase SSB above the control.  Correspondingly, the OTX-AGE electrophoresis again 
showed no significantly higher levels of SSB above controls.  Based on these findings, 
we are inclined to propose that the genotoxicity induced by Cr(VI) in DT40 cells is not 
due to oxidative stress.                
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Chapter IV Figures. 
 
 
 
 
 
 
 
 
 
 
 
           
  
  
    
  
     
  
 
 
 
Figure 4-1.  Forms of chromium(VI) in aqueous solution
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Figure 4-2. Major steps in the uptake, metabolism 
and formation of DNA damage caused by Cr(VI). 
Salnikow and Zhitkovich, (2008) Chem. Res. Toxicol., 21, 28-44.
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Figure 4-3.  Putative Asc-Cr-DNA ternary adduct. 
(Adapted from Zhitkovich et al., 2001)
Figure 4-4.  Formation of microchelate adducts of Cr(III) with 
DNA. (A) Direct coordination of Cr(III) to 5’-phosphate and N-
7 of dG. (B) Direct coordination of Cr(III) to 5’-phosphate with 
hydrogen bonding to N-7 of dG.  (Adapted from Zhitkovich et 
al., 2001)
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Figure 4-5. Relative LC50 values of cell survival results in DT40 parental and 
HR or NHEJ mutant cells exposed to potassium chromate.  Each LC50 value 
was calculated from cells survival results and were normalized to the LC50 
value of the parental DT40 cells (wt). Significance calculated using Student’s t
test.
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Figure 4-6. Relative LC50 values of cell survival results in DT40 parental 
and BER or NER mutant cells exposed to potassium chromate.  Each LC50 
value was calculated from cells survival results and were normalized to the 
LC50 value of the parental DT40 cells (wt). Significance calculated using 
Student’s t test.
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4 hour Toxicity Test of DT40 Parental Cells Exposed to Cr(VI)
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Figure 4-7. Result of 4-hour continuous exposure of parental DT40 cells to 
the indicated Cr(VI) concentration. Bars represent percentage increase in 
cell count performed by hemacytometer. Significance calculated using 
Student’s t test.
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Figure 4-8. Result of assay to determine level of 8-oxo-dG due to 
exposure to potassium chromate.  DT40 wt cells where exposed to the 
indicated concentrations of chromate for 4 h. Result of exposure to 
H2O2 for 0.5 h is shown as a positive control. A Student’s t test 
indicated no significant difference between the samples from the
chromate control, 30 µM and 60 µM treatments. NS: no statistical 
significance from control (Student’s t test).
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Figure 4-9. Result of NAD(P)H depletion assay performed with DT40 
parental cells. (A) Cells continuously exposed to increasing concentrations of 
potassium chromate or potassium chromate plus the PARP inhibitor 3-AB for 
4 h.  (B) Cells continuously exposed to MMS or MMS plus 3-AB for 4 h.
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Figure 4-10. Result of GGE SSB assay for DT40 
parental cells exposed to 0, 30 and 60 uM (two 
samples each) potassium chromate for 4 h. 
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Figure 4-11. Result of OTX-AGE SSB assay for 
DT40 parental cells exposed to 0, 30 and 60 uM
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Figure 4-13. Detection of DNA replication tracks indicating: red tracks, 
pre-Cr exposure IdU incorporation and; green tracks, post-Cr exposure 
CldU incorporation.  
Unexposed
After exposure a.
b. c.
d. No green only tracks
Merging forks
Figure 4-14. Visualization of replication using DNA combing. Red 
tracks indicate IdU incorporation, green tracks indicate CldU
incorporation. Possible effects of exposure (indicated by lightning 
bolt): a. No effect; b. fork progression slowed; c. premature 
termination; d. replicon initiation inhibited
Replication origin
Newly fired origin
Diverging forks
Normal elongation
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Figure 4-15. Chromium Slightly Increases Terminations
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Figure 4-16.  Chromium Alters Origin Initiation
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Figure 4-17. Effect of chromate exposure on replication rate in wt DT40 cells. The 
ratio of red/green track lengths should be approximately 1:1 as shown here for the 
sham dose. Exposure to chromate has increased the red/green ratio in a dose 
dependent manner indicating slowing of replication fork progression. 
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Figure 4-18. Proposed and reported possible types of DNA damage 
induced by hexavalent chromium.
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Chapter 5. General Discussion 
Summary and Conclusions 
 Considering the sizeable number of new chemicals that are being synthesized 
each year, when added to the huge number that already exists, it is a simple matter to 
understand the daunting task that regulatory bodies and others around the world have 
when determining the safe levels of exposure for humans and the environment.  To aid in 
these determinations, scientists have made use of a variation of methodologies including 
the Ames test, animal toxicity studies, yeast reverse-genetic assays, studies with 
mammalian cells, various in vitro procedures and others.  In this work we have made use 
of a very modern approach which takes advantage of the dozens of mutants available in 
the chicken B-lymphocyte, or DT40, cell system.  This system presents a considerable 
advantage over others in that the complete system has been generated from a single 
parent and is thus isogenic.  One obvious benefit from such a system is that it removes 
uncertainties inherent when several mutants are used for the determination of DNA 
damage response, but each mutant is from different cell lines with dissimilar genetic 
backgrounds.  Conclusions made as a result of responses across these different cell lines 
are thus made more tentative due to unknown reactivities of proteins in the pathways 
being studied and particularly those of associated pathways.  Other advantages of the 
DT40 cell line, such as the comparatively very high targeting efficiency of transfected 
DNA, its stable karyotype over long periods of culturing and its lack of demonstrable p53 
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activity have combined to make this cell line very attractive indeed for studies of not only 
metabolic pathways, but now, with our work, for DNA damage response assessments of 
toxicants as well.  
 This project has endeavored to develop, assess and validate a new high-
throughput applicable methodology for the use of the DT40 cell system for the 
determination of the DNA damage response to exogenous and endogenous agents.  The 
method developed here has dispensed with the more cumbersome, time consuming and 
expensive clonogenic assay which normally suffices quite well for metabolic pathway 
analyses and replaced it with a convenient, less expensive and much more rapid analysis 
which we feel has definite potential for automation.  This would thus create a high-
throughput process regulatory agencies could use to screen new chemicals in a much 
more timely manner. 
 Development of this assay has been performed during Specific Aim 1 of this 
project and consisted of combining two existing systems, the DT40 cells system, and the 
XTT cell proliferation assay to determine the response of the cells to chemicals such as 
MMS and cisplatin.  These tests demonstrated that the assay could provide excellent 
reproducibility (as exemplified by the MMS result) as well as strongly comparable results 
with the clonogenic method as demonstrated by our cisplatin results.  We were then able 
to further verify the viability of our system by assessing the DNA damage response to 
acrolein – the first environmental pollutant to be tested with this system.  Our results with 
Acr generally agreed very well with the literature reports concerning damage pathway 
responses to Acr.   
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 To further assess the validity of our assay we chose, in Specific Aim 2, to use our 
method to evaluate the DNA damage response to formaldehyde – a chemical shown to 
induce DPC.  At the time, little was known about how cells deal with these lesions.  We 
were able to show for the first time that cells deficient in the FANC/BRCA pathway are 
not only hypersensitive to formaldehyde, but the sensitivity is detectable at 
concentrations of formaldehyde that commonly found in human blood plasma.  To help 
further verify our findings, we exposed two human cell mutants that are members of the 
FANC/BRCA pathway – FANCC and FANCG – and found they are also quite sensitive 
to formaldehyde.  Based on these findings we were able to conclude that the 
FANC/BRCA pathway is essential for the removal of DPC and that endogenous levels of 
formaldehyde may have an effect on rapidly proliferating cell, such as bone marrow cells, 
and that an etiology of cancer due to formaldehyde exposure in Fanconi anemia patients 
may exist.  In Specific Aim 3 we chose to further assess the value of the assay to 
toxicologists by evaluating the response of our DT40 system to another, completely 
different sort of chemical, the inorganic salt of the metal chromium – potassium chromate.  
Hexavalent chromium is a known human carcinogen for which a substantial number of 
reports have suggested several different types of possible damage to DNA that may be 
responsible for its mutagenicity.  Nevertheless, even after decades of study, the avenue to 
chromate-induced mutagenicity is still not completely understood.  After repeated trials 
with chromate against our DT40 mutants, we found the system to give very consistent 
results which indicated agreement as well as disagreement with some of the conclusions 
of others.  Our DNA damage response results indicated that chromate presents a block to 
replication forks resulting in fork stalling and error-prone repair by a TLS bypass 
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polymerase.  This conclusion is in agreement with accumulated works of others.  Also, 
many studies have, using various techniques, espoused the idea that oxidative-stress 
related damage is induced by chromate.  Our DNA damage response analysis also 
indicated a pattern consistent with that caused by exposure to hydrogen peroxide – a 
strong generator of oxidative stress.  In this situation, however, we determined to use the 
DT40 cells for follow-up studies to further investigate the possibility of chromate-
induced oxidative stress.  These studies, the evaluation of 8-oxo-dG, and the level of 
DNA single-strand breaks as determined by the NAD(P)H depletion assay, the GGE and 
the OTX-AGE tests, indicated that chromate-induced oxidative stress is unlikely in DT40 
cells.   
 Thus, with this chromium study we have been able to demonstrate another 
tremendous value of this assay – the ability to lead us in the direction of expanded studies 
to further characterize the genotoxicity of a toxicant, and just as importantly, to possibly 
deter us from following paths that are most likely to prove unproductive. 
  
Future Directions 
 Although the method we have developed here has provided a convenient and 
relatively speedy assay for determining the DNA damage response to exogenous as well 
as endogenous agents, for the method to gain the most value to regulatory agencies the 
assay needs to be automated.  We believe this is possible with existing instrumentation.  
Equipment is available which is capable of culturing and maintaining the cells as well as 
automatically seeding and exposing them in multi-well plates.  Automation should allow 
for many more tests to be performed daily with relatively little human intervention and 
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should also lessen the variability due to pipetting variation inherent with human 
involvement.   
 We also envision a continuation of our study of chromium toxicity although we 
currently do not have the resources to perform the work ourselves.  Although we found 
no significant increase in the 8-oxo-dG levels above controls, it has been reported that 8-
oxo-dG may be susceptible to further oxidation to the compound spiroiminodihydantion 
(Sp) as well as other possible advanced oxidation products (Slade et al., 2005).  In this 
study the authors found that the lesion formed on double-stranded DNA was trapped 
nearly exclusively by the BER protein mNEIL2 rather than hOGG1 indicating that Sp 
was the major form of the oxidative damage induced by chromate (Sp lesions were 
approximately 20-fold more numerous than 8-oxo-dG).  As the Slade experiment was 
conducted in vitro on naked DNA, we think it would be interesting to clarify the 
importance of this advanced oxidation of dG in DT40 and human cells.  
 Another interesting aspect of our chromium research concerns the path by which 
chromate is reduced in DT40 cells.  It has been determined that chromate is reduced in 
the cytoplasm via a two-electron reduction by ascorbate or one-electron reduction by 
glutathione or cysteine.  The two-electron reduction would bypass the most likely culprit 
for inducing oxidative stress – Cr(V).  Thus, it would be very interesting to ascertain the 
level of ascorbate existing in DT40 cells to determine if the lack of observed markers of 
oxidative stress may be due to relatively high levels of ascorbate in chicken cells.   
 Another interesting possibility would be to perform the DNA fiber analysis on 
some chosen DT40 mutants.  The preliminary data we have gathered using this assay 
have been the result of exposure of chromate to parental DT40 cells only.  Since the data 
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show a strong indication that replication forks are stalling due to chromate exposure, 
performing the same experiments with DT40 mutants deficient in double-strand break 
repair, for instance, may provide more clarification in regard to this phenomenon.  
 Finally, we feel quite strongly that we have developed what may become a very 
important new assay to aid in the determination of how chemicals are inducing 
genotoxicity in cells.  Although we understand that much more validation with many 
more chemicals is necessary, we look forward to a time when this assay could take its 
place among the array of other assays that regulators and others use in the determination 
of the modes of action of the multitude of agents for which not enough is known about 
their means to cause harm to the genome.                        
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Appendix A.  Statistical Analysis 
 
Figure A-1. Parametric (linear or quadratic model) fit of the relation between Acrolein 
dosage and survival proportion (black solid line), the corresponding 95% prediction CI 
(dash line), and the MED (the intersection of the upper bound of 95% CI and the 
horizontal line: survival proportion = 0). The star (*) next to a p-value indicates the 
model is a quadratic model, otherwise the model is linear model. 
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Table A-1. Contingency table comparison of the MED estimated from our parametric 
approach based on linear/quadratic models and a non-parametric approach (Williams 
1986).  
 
 
 
  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MED from linear  
or quadratic model 
MED estimated by Williams (1986) 
 (0,0.5] (0.5,0.71] (0.71,1.0] (1.0,1.41] (1.41,2.0] (2.0,2.83] 
(0,0.5] 0 1 0 0 0 0 
(0.5,0.71] 1 2 0 0 0 0 
(0.71,1.0] 0 1 2 4 0 0 
(1.0,1.41] 0 0 0 11 0 0 
(1.41,2.0] 0 0 0 2 5 1 
(2.0,2.83] 0 0 0 0 0 0 
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Figure A-2. The 95% prediction CIs of the difference between different cell lines and cell 
line DT40 and the minimum dose where two cell lines have significant different 
responses (if it exits). 
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